Submitted URL: http://link.email.empr.com/a/1323/click/65762/2303653/26edc65a5c1fa723b411a199e46052e7e9c16db8/9e0d2ded1a9fae7b27de8f0638a3...
Effective URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_...
Submission: On August 26 via api from US

Summary

This website contacted 46 IPs in 8 countries across 35 domains to perform 238 HTTP transactions. The main IP is 3.225.154.29, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.empr.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on January 16th 2019. Valid for: 2 years.
This is the only time www.empr.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 35.238.92.4 15169 (GOOGLE)
34 3.225.154.29 14618 (AMAZON-AES)
24 94.31.29.64 33438 (HIGHWINDS2)
3 2a00:1450:400... 15169 (GOOGLE)
1 93.184.220.113 15133 (EDGECAST)
11 2a00:1450:400... 15169 (GOOGLE)
4 52.216.162.253 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:205... 16509 (AMAZON-02)
10 172.217.16.194 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 7 2a00:1450:400... 15169 (GOOGLE)
1 4 2.19.43.224 20940 (AKAMAI-ASN1)
4 2a00:1450:400... 15169 (GOOGLE)
1 13.35.253.5 16509 (AMAZON-02)
3 2a03:2880:f01... 32934 (FACEBOOK)
2 2 54.156.255.160 14618 (AMAZON-AES)
2 2 35.227.248.159 15169 (GOOGLE)
1 34.225.65.223 14618 (AMAZON-AES)
1 13.35.255.55 16509 (AMAZON-02)
67 2606:4700:20:... 13335 (CLOUDFLAR...)
1 34.192.84.248 14618 (AMAZON-AES)
3 52.1.219.33 14618 (AMAZON-AES)
2 8 34.248.158.173 16509 (AMAZON-02)
1 13.35.253.69 16509 (AMAZON-02)
2 2 2a00:1450:400... 15169 (GOOGLE)
2 4 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
3 2a03:2880:f11... 32934 (FACEBOOK)
2 35.227.192.113 15169 (GOOGLE)
4 52.4.48.124 14618 (AMAZON-AES)
4 34.205.176.240 14618 (AMAZON-AES)
4 2600:9000:205... 16509 (AMAZON-02)
1 13.35.253.36 16509 (AMAZON-02)
2 13.35.253.52 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
4 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
2 5 2600:1f14:e96... 16509 (AMAZON-02)
1 54.218.116.18 16509 (AMAZON-02)
1 34.210.86.189 16509 (AMAZON-02)
2 54.202.239.230 16509 (AMAZON-02)
1 54.208.174.93 14618 (AMAZON-AES)
1 1 23.43.115.74 20940 (AKAMAI-ASN1)
2 2 35.190.72.21 15169 (GOOGLE)
2 2 2.21.37.45 20940 (AKAMAI-ASN1)
2 3 54.76.79.46 16509 (AMAZON-02)
2 3 18.185.83.216 16509 (AMAZON-02)
1 34.192.232.20 14618 (AMAZON-AES)
1 54.194.184.41 16509 (AMAZON-02)
238 46
Apex Domain
Subdomains
Transfer
69 lytics.io
c.lytics.io
api.lytics.io
90 KB
35 empr.com
link.email.empr.com
www.empr.com
media.empr.com
3 MB
24 netdna-ssl.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
263 KB
19 b2c.com
api.b2c.com
api-54-218-116-18.b2c.com
api-34-210-86-189.b2c.com
api-54-202-239-230.b2c.com
26 KB
12 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
104 KB
10 googlesyndication.com
tpc.googlesyndication.com Failed
pagead2.googlesyndication.com
154 KB
9 ml314.com
ml314.com
in.ml314.com
17 KB
9 haymarketmedia.com
accounts.haymarketmedia.com
subapi.haymarketmedia.com
adtrackapi.haymarketmedia.com
12 KB
7 google-analytics.com
www.google-analytics.com
41 KB
6 spotible.com
ads.spotible.com
cdn1.spotible.com
709 KB
5 google.com
adservice.google.com
www.google.com
1002 B
5 googletagservices.com
www.googletagservices.com
124 KB
4 gstatic.com
fonts.gstatic.com
50 KB
4 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 amazonaws.com
s3.amazonaws.com
2 MB
4 crwdcntrl.net
tags.crwdcntrl.net
sync.crwdcntrl.net
bcp.crwdcntrl.net
13 KB
3 eyeota.net
ps.eyeota.net
1 KB
3 facebook.com
www.facebook.com
323 B
3 medtargetsystem.com
www.medtargetsystem.com
52 KB
3 sitomobile.com
mt.sitomobile.com
sp.sitomobile.com
2 KB
3 facebook.net
connect.facebook.net
103 KB
3 google.de
adservice.google.de
www.google.de
959 B
3 googleapis.com
fonts.googleapis.com
2 KB
2 mathtag.com
pixel.mathtag.com
1 KB
2 rlcdn.com
idsync.rlcdn.com
843 B
2 adsrvr.org
js.adsrvr.org
insight.adsrvr.org
2 KB
2 tapad.com
pixel.tapad.com
841 B
2 maropost.com
content.maropost.com
mpct1.maropost.com
5 KB
1 deepintent.com
match.deepintent.com
212 B
1 bluekai.com
tags.bluekai.com
856 B
1 renalandurologynews.com
www.renalandurologynews.com
9 KB
1 alexametrics.com
certify.alexametrics.com
551 B
1 cloudfront.net
d31qbv1cthcecs.cloudfront.net
2 KB
1 crazyegg.com
script.crazyegg.com
28 KB
1 googletagmanager.com
www.googletagmanager.com
34 KB
238 35
Domain Requested by
67 c.lytics.io 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
c.lytics.io
www.empr.com
33 www.empr.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
24 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
10 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.empr.com
8 ml314.com 2 redirects www.empr.com
ml314.com
7 api-54-202-239-230.b2c.com 2 redirects www.empr.com
7 www.google-analytics.com 2 redirects www.googletagmanager.com
www.google-analytics.com
6 tpc.googlesyndication.com securepubads.g.doubleclick.net
5 www.googletagservices.com www.empr.com
securepubads.g.doubleclick.net
4 api-34-210-86-189.b2c.com 1 redirects www.empr.com
4 api-54-218-116-18.b2c.com 1 redirects www.empr.com
4 api.b2c.com securepubads.g.doubleclick.net
www.empr.com
4 adtrackapi.haymarketmedia.com s3.amazonaws.com
4 pagead2.googlesyndication.com www.empr.com
4 ads.spotible.com www.empr.com
ads.spotible.com
4 subapi.haymarketmedia.com s3.amazonaws.com
4 www.google.com 2 redirects securepubads.g.doubleclick.net
4 fonts.gstatic.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
4 sb.scorecardresearch.com 1 redirects www.empr.com
www.googletagmanager.com
4 s3.amazonaws.com www.empr.com
3 ps.eyeota.net 2 redirects www.empr.com
3 www.facebook.com www.empr.com
connect.facebook.net
3 www.medtargetsystem.com www.empr.com
www.medtargetsystem.com
3 connect.facebook.net www.empr.com
connect.facebook.net
3 fonts.googleapis.com www.empr.com
s3.amazonaws.com
2 sync.crwdcntrl.net 2 redirects
2 pixel.mathtag.com 2 redirects
2 idsync.rlcdn.com 2 redirects
2 cdn1.spotible.com www.empr.com
2 api.lytics.io c.lytics.io
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
2 www.google.de www.empr.com
2 stats.g.doubleclick.net 2 redirects
2 pixel.tapad.com 2 redirects
2 mt.sitomobile.com 2 redirects
1 insight.adsrvr.org js.adsrvr.org
1 bcp.crwdcntrl.net tags.crwdcntrl.net
1 match.deepintent.com www.empr.com
1 tags.bluekai.com 1 redirects
1 in.ml314.com ml314.com
1 media.empr.com www.empr.com
1 www.renalandurologynews.com www.empr.com
1 certify.alexametrics.com www.empr.com
1 accounts.haymarketmedia.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
1 mpct1.maropost.com content.maropost.com
1 js.adsrvr.org www.googletagmanager.com
1 sp.sitomobile.com www.empr.com
1 d31qbv1cthcecs.cloudfront.net www.empr.com
1 script.crazyegg.com www.googletagmanager.com
1 adservice.google.com www.googletagservices.com
1 adservice.google.de www.googletagservices.com
1 content.maropost.com www.empr.com
1 www.googletagmanager.com www.empr.com
1 tags.crwdcntrl.net www.empr.com
1 link.email.empr.com 1 redirects
238 54
Subject Issuer Validity Valid
*.empr.com
RapidSSL RSA CA 2018
2019-01-16 -
2021-01-15
2 years crt.sh
*.netdna-ssl.com
Sectigo RSA Domain Validation Secure Server CA
2019-02-18 -
2020-02-27
a year crt.sh
*.googleapis.com
Google Internet Authority G3
2019-07-29 -
2019-10-21
3 months crt.sh
tags.crwdcntrl.net
DigiCert SHA2 Secure Server CA
2019-03-15 -
2021-04-07
2 years crt.sh
*.g.doubleclick.net
Google Internet Authority G3
2019-07-29 -
2019-10-21
3 months crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2018-12-03 -
2019-10-25
a year crt.sh
*.google-analytics.com
Google Internet Authority G3
2019-07-29 -
2019-10-21
3 months crt.sh
content.maropost.com
Amazon
2018-10-25 -
2019-11-25
a year crt.sh
*.google.com
Google Internet Authority G3
2019-07-29 -
2019-10-21
3 months crt.sh
ssl945600.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-20 -
2020-02-26
6 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.cloudfront.net
DigiCert Global CA G2
2018-10-08 -
2019-10-09
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-06-06 -
2019-09-04
3 months crt.sh
*.sitomobile.com
RapidSSL RSA CA 2018
2018-01-22 -
2020-07-29
3 years crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1
2019-03-07 -
2021-04-19
2 years crt.sh
*.maropost.com
Go Daddy Secure Certificate Authority - G2
2019-06-10 -
2021-08-09
2 years crt.sh
ssl379818.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-07-26 -
2020-02-01
6 months crt.sh
accounts.haymarketmedia.com
Amazon
2018-10-26 -
2019-11-26
a year crt.sh
medtargetsystem.com
Amazon
2018-11-23 -
2019-12-23
a year crt.sh
*.ml314.com
Amazon
2019-03-16 -
2020-04-16
a year crt.sh
certify.alexametrics.com
Amazon
2019-07-26 -
2020-08-26
a year crt.sh
www.google.de
Google Internet Authority G3
2019-07-29 -
2019-10-21
3 months crt.sh
*.lytics.io
RapidSSL TLS RSA CA G1
2018-01-26 -
2020-01-06
2 years crt.sh
subapi.haymarketmedia.com
Amazon
2019-06-28 -
2020-07-28
a year crt.sh
*.spotible.com
Go Daddy Secure Certificate Authority - G2
2016-10-16 -
2019-11-06
3 years crt.sh
adtrackapi.haymarketmedia.com
Amazon
2019-03-27 -
2020-04-27
a year crt.sh
*.renalandurologynews.com
RapidSSL RSA CA 2018
2019-02-22 -
2020-02-22
a year crt.sh
empr.com
Amazon
2018-11-08 -
2019-12-08
a year crt.sh
tpc.googlesyndication.com
Google Internet Authority G3
2019-07-29 -
2019-10-21
3 months crt.sh
www.google.com
Google Internet Authority G3
2019-07-29 -
2019-10-21
3 months crt.sh
*.b2c.com
Amazon
2019-03-24 -
2020-04-24
a year crt.sh
*.eyeota.net
Let's Encrypt Authority X3
2019-07-11 -
2019-10-09
3 months crt.sh
*.deepintent.com
Go Daddy Secure Certificate Authority - G2
2018-06-08 -
2020-06-08
2 years crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2019-06-13 -
2021-06-28
2 years crt.sh

This page contains 11 frames:

Primary Page: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Frame ID: 4C3D604E4ACCAA6BEAE5384FE02FA15B
Requests: 206 HTTP requests in this frame

Frame: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/74508fc76dca5391fdb5ee5585bcc1af?segments=true&mergestate=true&ts=1566796372700
Frame ID: 5FCBC745E05539F0D7366FFC57FDE52D
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 3E57E25F5F5F5872213A3531756D2C25
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 9A78E4D48DBA2309CC5F9CF725032914
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 464230FAF33925F64362EB1DB362F4AE
Requests: 2 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssoOUH3kge1_RIXeTsWEAfKbjuZZ4tmEw6dU8qOjCeNtT1I5UZXz36ZRBC8tSho4ZBnJKmcnMgKa6HvHIHjSY51AZn0dgGoGRbHyGPhqLSPxblWGIWGfTsWxQjGcRtRcJhzNsyTvweJPw4xSD4UtZnXLBnNM2JRCWdCvCmQZk6CP9kfs5FQGR4rqRWOFBlClYzZ1IWQL2aH9f6IT7qVVcTUGtOf1GVDu-TX32QtAVrEC0eR86CGvsIukiifyoYstpEUqDts9malHXvQ2g9FXay8OQ&sig=Cg0ArKJSzOWy6fCdKCVmEAE&adurl=
Frame ID: ECE43373E3364788CE976023064DAD86
Requests: 11 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssi_NJmuTODU_jA09UzdTHzw35cQ1agTvxcSmT2zqIr2u5GMmtMNZPnqaQ9us89wxraZUJZU-qCFvv3HgVmQOqv5oCdWQJZMwkCtI_tGhSf1-6KnoA1hAQAFK24oiIM45-pja7nGQAfZPrNe4LXGk1pimroAIbTcIKJLhBcBd50pLFj2Pw835s0X32DdLGOXpWsHmjSdlze_GdIVECZxd4mlw29M1ksvX61AldNR142ohqWKynPPn8TUqd4jXU7OiWm2ugygEu_iA&sig=Cg0ArKJSzL0tycMarAYgEAE&adurl=
Frame ID: 7AC436714DE4C6A9B7A87C4A95B708F6
Requests: 11 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvBjhI2Wi5eCLaKXfsotoaM2JM_eQlOP3C11S1UCUEjdUegghyixWtvLf6gYzIxAh8jUP6KcosBnkERI_2loLKmjOO0sMeDgzFjgWi3Ew9rXVu1bAf8UvpY3P7yk4Igy0HwHkPGophCP9NeaYlYkZkh9I8IP8MKHZUdu-BQk8na7PtrRZLOUiyTzR8dBW1pJMSXhxCSEW-Sp6ztpPr_bugYPDvEUBQzupStihyYnyFgpm6tYbNO7NQSpqA5KouDv9WkaFZRdmr0&sig=Cg0ArKJSzPq3FA0eUWu0EAE&adurl=
Frame ID: DD22DD1CC630D5E6631F90C463D4FB17
Requests: 10 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F&_sid=3651babf-7e80-49f7-ae09-8001f3f97c77&_vid=87548eea-bafb-4017-acc1-e52d49e0627a&_ak=35-212-8F62AC13&_flash=false&_th=1566796372|1566796372|1
Frame ID: 3A3C930F80C0BA9DF35C90CA0F9D92A9
Requests: 1 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/c=14413/rand=617739255/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/med=%23OpR%2397539%23Article%20Tags%20%3A%20Cardiovascular%20Disease%2CCHF%20and%20Arrhythmias%2CDiabetes%2CEndocrine%20Disorders/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653%22%7D/rt=ifr
Frame ID: E4764677B2A786CBBCCA519D7AB7B8BF
Requests: 1 HTTP requests in this frame

Frame: https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&upid=7fhq4wn&upv=1.1.0
Frame ID: 75509CE4381E8E839D0D16D652B0E8D9
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://link.email.empr.com/a/1323/click/65762/2303653/26edc65a5c1fa723b411a199e46052e7e9c16db8/9e0d2ded... HTTP 302
    https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

238
Requests

100 %
HTTPS

37 %
IPv6

35
Domains

54
Subdomains

46
IPs

8
Countries

6333 kB
Transfer

8660 kB
Size

46
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://link.email.empr.com/a/1323/click/65762/2303653/26edc65a5c1fa723b411a199e46052e7e9c16db8/9e0d2ded1a9fae7b27de8f0638a324d2dc31cb7c&amp HTTP 302
    https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1566796371983&ns_c=UTF-8&c8=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566796371983&ns_c=UTF-8&c8=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&c9=
Request Chain 49
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://mt.sitomobile.com/sync/tacb?exid=28119540-c7c0-11e9-9128-aa3756790559&aid=136&sid=hmm&val=12 HTTP 302
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Request Chain 63
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=62581692&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&ul=en-us&de=UTF-8&dt=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAAAAjQ~&jid=733643057&gjid=4173117&cid=1731879218.1566796372&tid=UA-1290429-2&_gid=963010317.1566796372&_r=1&gtm=2wg8e15XFK9V6&cd1=122567%3A0&cd2=cardiovascular%20disease%2Cchf%20and%20arrhythmias%2Cdiabetes%2Cendocrine%20disorders&cd3=&cd4=&cd5=post&cd6=&cd7=home&cd8=news&cd9=dapagliflozin%20reduces%20risk%20of%20cv%20death%2C%20hospital%20admission%20in%20heart%20failure%20trial&cd11=omn&cd12=13&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=Diana%20Ernst%2C%20RPh&cd35=News&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=9&cd57=&cd58=&cd62=false&cd63=2019-08-21&cd64=267&cd67=&cd68=undef&cd71=false&cd78=false&cd79=false&cd80=false&cd93=news&z=1378880558 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_gid=963010317.1566796372&gjid=4173117&_v=j79&z=1378880558 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_v=j79&z=1378880558 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_v=j79&z=1378880558&slf_rd=1&random=2276880429
Request Chain 215
  • https://api-54-218-116-18.b2c.com/api/x?e1PFsqwueEu4tciR$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 HTTP 302
  • https://api-54-218-116-18.b2c.com:444/api/4?e1PFsqwueEu4tciR
Request Chain 216
  • https://api-34-210-86-189.b2c.com/api/x?qKckBLjFuIRU70XP$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 HTTP 302
  • https://api-34-210-86-189.b2c.com:444/api/4?qKckBLjFuIRU70XP
Request Chain 217
  • https://api-54-202-239-230.b2c.com/api/x?D4aBZsqOQNZEhrZu$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 HTTP 302
  • https://api-54-202-239-230.b2c.com:444/api/4?D4aBZsqOQNZEhrZu
Request Chain 220
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151491901843217&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151491901843217%26eid=50056 HTTP 302
  • https://ml314.com/csync.ashx?fp=KW0mmy9999OHmZB5&person_id=5978151491901843217&eid=50056
Request Chain 221
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151491901843217 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5MTkwMTg0MzIxNxAAGg0I2NSN6wUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=b102507a09a4c8d67e28f64eefa7aa03732ba9dbe812d2580661b5446b3e34f5f4cb09cee1a4f8eb&person_id=5978151491901843217&eid=50082
Request Chain 222
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151491901843217%26eid=50220 HTTP 302
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151491901843217%26eid=50220&mm_bnc&mm_bct&UUID=15615d63-6801-4900-83bb-5062ac793b5d HTTP 302
  • https://ml314.com/csync.ashx?fp=15615d63-6801-4900-83bb-5062ac793b5d&person_id=5978151491901843217&eid=50220
Request Chain 223
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151491901843217 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151491901843217 HTTP 302
  • https://ml314.com/csync.ashx?fp=54025932f3151c3b52e81cff0c3acf35&eid=50146&person_id=5978151491901843217
Request Chain 224
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif HTTP 302
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif HTTP 302
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2Zgj5vbRCXrzaBicYE9Y0edppXG04R-68ONCJVWmN62Y&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil HTTP 302
  • https://ml314.com/csync.ashx?fp=2Zgj5vbRCXrzaBicYE9Y0edppXG04R-68ONCJVWmN62Y&person_id=5978151491901843217&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil HTTP 302
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Request Chain 243
  • https://api-54-202-239-230.b2c.com/api/x?lCmFdXwyBAnXFsg7$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RhcGFnbGlmbG96aW4tcmVkdWNlcy1yaXNrLW9mLWN2LWRlYXRoLWhvc3BpdGFsLWFkbWlzc2lvbi1pbi1oZWFydC1mYWlsdXJlLXRyaWFsLz91dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX21lZGl1bT1lbWFpbCZ1dG1fY2FtcGFpZ249bXByLWRhaWx5ZG9zZS1oYXktMjAxOTA4MjYmY3BuPXBjcF9tZCxmcF9tZCxwY3BfYWxsLGhhcnZvbml0YmcsZXBjbHVzYWxpc3RiX2phbjIwMTksZXBjbHVzYV9hcHJpbF8yMDE5JmhtU3ViSWQ9JmhtRW1haWw9OHQ4NU9hTW5BdGRzZVlsMUtzSFZXcGVWcDF3MTQ4dGJQY016QXVVY2s1RTEmTklEPTE2MTk5MDk5NzUmY19pZD0mZW1haWxfaGFzaD0xM2ZjZjgwYjgwOTdlZWQxODZlMDdkYjE5ZmQzYzJjNiZkbD0wJm1wd2ViPTEzMjMtNjU3NjItMjMwMzY1MyIsInJlZmVycmVyJDAkIiwiYW5jZXN0b3JPcmlnaW5zJDAkIiwidmlkZW8kMCQxNjAweDEyMDB4MjQiLCJmcmFtZSQwJDAiLCJoaWRkZW4kMCQwIiwidmlzaWJpbGl0eVN0YXRlJDEkdmlzaWJsZSIsImhhc0ZvY3VzJDEkMSIsIndpbmRvdyQxJDE1ODV4MTIwMCIsImlubmVyJDEkMTYwMHgxMjAwIiwib3V0ZXIkMSQxNjAweDEyMDAiLCJsb2NhbFN0b3JhZ2UkMSRFcnJvcjogVHlwZUVycm9yOiBDYW5ub3QgcmVhZCBwcm9wZXJ0eSAnc2V0SXRlbScgb2YgbnVsbCIsInNlc3Npb25TdG9yYWdlJDIkMSIsImFwcENvZGVOYW1lJDIkTW96aWxsYSIsImFwcE5hbWUkMiROZXRzY2FwZSIsImFwcFZlcnNpb24kMiQ1LjAgKE1hY2ludG9zaDsgSW50ZWwgTWFjIE9TIFggMTBfMTRfNSkgQXBwbGVXZWJLaXQvNTM3LjM2IChLSFRNTCwgbGlrZSBHZWNrbykgQ2hyb21lLzc0LjAuMzcyOS4xNjkgU2FmYXJpLzUzNy4zNiIsImNvb2tpZUVuYWJsZWQkMiR0cnVlIiwiZG9Ob3RUcmFjayQyJCIsImhhcmR3YXJlQ29uY3VycmVuY3kkMiQxNiIsImxhbmd1YWdlJDIkZW4tVVMiLCJwbGF0Zm9ybSQyJExpbnV4IHg4Nl82NCIsInByb2R1Y3QkMiRHZWNrbyIsInByb2R1Y3RTdWIkMiQyMDAzMDEwNyIsInNlbmRCZWFjb24kMiQxIiwidXNlckFnZW50JDIkTW96aWxsYS81LjAgKE1hY2ludG9zaDsgSW50ZWwgTWFjIE9TIFggMTBfMTRfNSkgQXBwbGVXZWJLaXQvNTM3LjM2IChLSFRNTCwgbGlrZSBHZWNrbykgQ2hyb21lLzc0LjAuMzcyOS4xNjkgU2FmYXJpLzUzNy4zNiIsInZlbmRvciQyJEdvb2dsZSBJbmMuIiwidmVuZG9yU3ViJDIkIiwiZm9udHJlbmRlciQzJDEiLCJ3ZWJnbCQ2JG4vYSIsIndlYmdsMiQ2JDAiLCJ0aW1lJDYkMTU2Njc5NjM3OTE5OCIsInRpbWV6b25lJDYkLTEyMCIsInBsdWdpbnMkNiROb25lIiwibWVtLXRvdGFsSlNIZWFwU2l6ZSQ2JDQ1LjA1MTIxIiwibWVtLXVzZWRKU0hlYXBTaXplJDYkMjcuOTU5MzU0IiwibWVtLWpzSGVhcFNpemVMaW1pdCQ2JDIxOTcuODE1Mjk2IiwidGltZS1mZXRjaFN0YXJ0JDYkMTUzIiwidGltZS1kb21haW5Mb29rdXBTdGFydCQ2JDE1MyIsInRpbWUtZG9tYWluTG9va3VwRW5kJDckMTU0IiwidGltZS1jb25uZWN0U3RhcnQkNyQxNTQiLCJ0aW1lLWNvbm5lY3RFbmQkNyQzNTMiLCJ0aW1lLXNlY3VyZUNvbm5lY3Rpb25TdGFydCQ3JDI0OSIsInRpbWUtcmVxdWVzdFN0YXJ0JDckMzUzIiwidGltZS1yZXNwb25zZVN0YXJ0JDckNTUxIiwidGltZS1yZXNwb25zZUVuZCQ3JDU1MiIsInRpbWUtZG9tTG9hZGluZyQ3JDU1NCIsInRpbWUtZG9tSW50ZXJhY3RpdmUkNyQxMjc3IiwidGltZS1kb21Db250ZW50TG9hZGVkRXZlbnRTdGFydCQ3JDIwNzAiLCJ0aW1lLWRvbUNvbnRlbnRMb2FkZWRFdmVudEVuZCQ3JDIxMDIiLCJ0aW1lLWRvbUNvbXBsZXRlJDckNzc5NiIsInRpbWUtbG9hZEV2ZW50U3RhcnQkNyQ3Nzk2IiwidGltZS1sb2FkRXZlbnRFbmQkNyQ3ODA1IiwibmF2aWdhdGlvbi1yZWRpcmVjdENvdW50JDckMCIsIm5hdmlnYXRpb24tdHlwZSQ3JG5hdmlnYXRlIiwiZ2xvYmFscy10aW1lJDE2JDEuMjI1IiwiZ2xvYmFscyQxNyRhMzc1MjVhMyIsImRvY3VtZW50LXRpbWUkMjMkMS4xOSIsImRvY3VtZW50JDIzJDljOTc5ODUyIiwiY29ubmVjdGlvbiQyMyQiLCJkb3dubGlua01heCQyMyQiLCJnZXRVc2VyTWVkaWEkMjMkMiIsImNsb2NrJDMwJDI2MDQiLCJiYXR0ZXJ5JDMxJDEgMSAwIEluZmluaXR5IiwiaW50ZXJzZWN0aW9uLXNpemUkMzQkMTU4NXgxMjAwIiwiaW50ZXJzZWN0aW9uJDM0JDMxIiwiYXVkaW9jb250ZXh0JDM2JGFmZTRmOWM0Iiwic29ydCQ2MyQxMC42MyIsImZyYW1lcmF0ZSQxNDAkODAiLCJhZGJsb2NrJDIwMyQw HTTP 302
  • https://api-54-202-239-230.b2c.com:444/api/4?lCmFdXwyBAnXFsg7
Request Chain 244
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=62581692&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&ul=en-us&de=UTF-8&dt=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=User%20Engagement&ea=Beacon&_u=aGjAAAAjQ~&jid=1503703900&gjid=349550700&cid=1731879218.1566796372&tid=UA-1290429-2&_gid=1992434052.1566796387&_r=1&gtm=2wg8e15XFK9V6&cd13=No&z=200106176 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_gid=1992434052.1566796387&gjid=349550700&_v=j79&z=200106176 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_v=j79&z=200106176 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_v=j79&z=200106176&slf_rd=1&random=2630009453

238 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/
Redirect Chain
  • http://link.email.empr.com/a/1323/click/65762/2303653/26edc65a5c1fa723b411a199e46052e7e9c16db8/9e0d2ded1a9fae7b27de8f0638a324d2dc31cb7c&amp
  • https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=p...
100 KB
22 KB
Document
General
Full URL
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a36b641fd31423f37b770f98548b729c5e0d84ec9d01f95410836cf3c0eb76e3

Request headers

:method
GET
:authority
www.empr.com
:scheme
https
:path
/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
server
nginx
date
Mon, 26 Aug 2019 05:12:51 GMT
content-type
text/html; charset=UTF-8
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-distributor
yes
x-pingback
https://www.empr.com/xmlrpc.php
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/" <https://www.empr.com/?p=122567>; rel=shortlink
wpe-backend
apache
x-cacheable
SHORT
cache-control
max-age=600, must-revalidate
x-cache
HIT: 1
x-pass-why
x-cache-group
normal
x-wpengine-segment
NONHT
content-encoding
gzip

Redirect headers

Content-Type
text/html; charset=utf-8
Transfer-Encoding
chunked
Connection
keep-alive
Status
302 Found
Cache-Control
no-cache
X-XSS-Protection
1; mode=block
X-Request-Id
dcee72cf-d322-43d6-96ee-2cadc6c80944
Location
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
X-Runtime
0.030400
X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
Date
Mon, 26 Aug 2019 05:12:51 GMT
Set-Cookie
_session_id=1c2b682871464e3da722ae10e3f1bad0; path=/; expires=Mon, 26 Aug 2019 17:12:51 -0000; HttpOnly
X-Powered-By
Phusion Passenger 5.3.4
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/
29 KB
5 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/style.min.css?ver=5.2.2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Mon, 22 Apr 2019 12:40:04 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cbdb624-726f"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
shared-style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
48 KB
7 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-c05a"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
239 KB
32 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1564580337
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
7c98b3e37bc9c2a726c320f5db6e1e5a23c2c44d1a5aa35c6fb5e9ae78e64c86

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Wed, 31 Jul 2019 13:38:57 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d4199f1-3bcc2"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
css
fonts.googleapis.com/
8 KB
860 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 26 Aug 2019 05:12:51 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Mon, 26 Aug 2019 05:12:51 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:51 GMT
lytics.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
37 KB
3 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1561986242
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
ece5f25bbc643556099a200aa2df5c428d74048e55db71c1880afd1adcb425a9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Mon, 01 Jul 2019 13:04:02 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d1a04c2-95f6"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
css
fonts.googleapis.com/
825 B
409 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Bree+Serif&ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 26 Aug 2019 05:12:51 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Mon, 26 Aug 2019 05:12:51 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:51 GMT
autosuggest.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/
766 B
580 B
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/autosuggest.min.css?ver=3.0.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-2fe"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
jquery.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
95 KB
34 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Fri, 17 May 2019 17:08:53 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cdeeaa5-17a69"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
jquery-migrate.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
10 KB
4 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Fri, 20 May 2016 06:11:28 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"573eaa90-2748"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
cookie.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-834"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
cc.js
tags.crwdcntrl.net/c/14413/
38 KB
11 KB
Script
General
Full URL
https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
93.184.220.113 London, United Kingdom, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (ams/498D) /
Resource Hash
3c0c418574419249b3fff12c4cdb9a2ad6ddc191fa025ea56d4027552487e78c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Tue, 13 Aug 2019 19:05:38 GMT
server
ECS (ams/498D)
etag
"5d530a02-98ef+gzip"
vary
Accept-Encoding
x-cache
HIT
content-type
application/javascript
status
200
cache-control
max-age=86400
content-length
11304
expires
Tue, 27 Aug 2019 05:12:51 GMT
digest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
16 KB
5 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/digest.min.js?ver=2.0
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Wed, 22 May 2019 09:37:40 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5ce51864-3fc1"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
UtilityMove-custom.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-751"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
polyfill.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/
102 KB
35 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-19873"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
gpt.js
www.googletagservices.com/tag/js/
35 KB
12 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
58649dc87a82c3fe3de185bc3e5da95f8f9357899abfc780e2bd14b2988e0c05
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"260 / 116 of 1000 / last-modified: 1566588880"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
12352
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:51 GMT
adtracking.js
s3.amazonaws.com/haymarket-adtracking-js/prod/
19 KB
19 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.162.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:53 GMT
Last-Modified
Tue, 15 Jan 2019 22:54:19 GMT
Server
AmazonS3
x-amz-request-id
4356DBCADF9312EE
ETag
"dc289fc811d6d3a62b068bfcda1f8f30"
Content-Type
application/javascript
x-amz-version-id
MlU6AsBGwcOjZYgQIgNYntESpQyo9BbN
Accept-Ranges
bytes
Content-Length
19158
x-amz-id-2
j43lShfuEIgW96jZ9HAIurH+etItujdLCQoCyXlGJOpxA4jKScFQLdtHPNhuExe3/UdA3KS6304=
head.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
43 KB
13 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/head.min.js?ver=1565874213
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
0891c01a43615c445e85a7d17eab463dfc3de87d3d1e6f023a996cc1680fe586

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Thu, 15 Aug 2019 13:03:33 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d555825-ac53"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
MPR-logo_website.png
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/
16 KB
16 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/MPR-logo_website.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
etag
"452a9f099947d43a38734d72a92e9193"
last-modified
Wed, 20 Mar 2019 21:55:07 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
HIT
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
16492
expires
Fri, 20 Sep 2019 11:57:16 GMT
gtm.js
www.googletagmanager.com/
135 KB
34 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
c20bb9511b5e428f8815ee2d9473a0a9c1eb96cad17caa13b3b2a292660623d0
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
br
last-modified
Mon, 26 Aug 2019 03:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
34345
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:51 GMT
Diana-Ernst-newprofile-pic-96x96.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/08/
3 KB
3 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/08/Diana-Ernst-newprofile-pic-96x96.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
50abb28802f1e77b63ff2dee64a92ab7f6f2e1df12b7d66d513fa21eacca57b4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
etag
"4c180f21b1b74a261040e1e9217c13a3"
last-modified
Sat, 17 Aug 2019 07:11:47 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
HIT
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
2589
expires
Tue, 24 Sep 2019 18:26:42 GMT
heartdisease_0613slideshow_392227.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/
42 KB
42 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/heartdisease_0613slideshow_392227.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
890868352843ce74ea2931a4b7a4b6ef2d735badf08aa80408a66ea64492e828

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
etag
"99a7975f101886211cf2e4ac8859e6fa"
last-modified
Wed, 20 Mar 2019 22:09:15 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
MISS
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
42639
expires
Wed, 25 Sep 2019 05:12:52 GMT
300x100mprsub-300x105.gif
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/
13 KB
14 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/300x100mprsub-300x105.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
etag
"fb86d90a5bcf340b8bd64802ec39a7a5"
last-modified
Wed, 20 Mar 2019 09:05:43 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
HIT
content-type
image/gif
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
13667
expires
Fri, 20 Sep 2019 12:38:00 GMT
spinner.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/src/
694 B
630 B
Image
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=2592000
96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js
content.maropost.com/uploads/1323/websites/5/
3 KB
3 KB
Script
General
Full URL
https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:a600:1b:fadc:b780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 09:04:41 GMT
via
1.1 62dc260e32d7b9197a4511447f6a264a.cloudfront.net (CloudFront)
last-modified
Thu, 27 Sep 2018 21:48:02 GMT
server
AmazonS3
age
72492
etag
"ff4375eccda3ca6bc54ed96c5d77d9bb"
x-cache
Hit from cloudfront
status
200
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
2622
x-amz-cf-id
wv8c6BJt_7D5mS2ZKzyRHXQPcc1TZF6PVkUKijr2Efr8Qfa0x03PkA==
blocks.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
7 KB
3 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1565874213
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2b2f53c9542f12eef99cceef17c6dad6692fe6d3630b9a22d0f6c4bba7b55002

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Thu, 15 Aug 2019 13:03:33 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d555825-1b42"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
local-storage-lib.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
1 KB
917 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/local-storage-lib.js?ver=2.0
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
last-modified
Wed, 17 Jul 2019 13:03:16 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d2f1c94-591"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
npi-manager.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
3 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/npi-manager.js?ver=2.0
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
ec4b201b52347534c07364e77ab720820b26bca36ffa7376cedfba0c25a3b796

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
last-modified
Wed, 17 Jul 2019 13:03:16 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d2f1c94-afc"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
hmi-registration-ui.manifest.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
799 B
1 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.162.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:53 GMT
Last-Modified
Thu, 01 Aug 2019 16:14:19 GMT
Server
AmazonS3
x-amz-request-id
F32865C1CE34A44A
ETag
"6878a8fbe72bde4a3f8ecf5b16523972"
Content-Type
application/javascript
x-amz-version-id
z4vE4G3HGR4cu6UpbJUCgMOgPPNEViV0
Accept-Ranges
bytes
Content-Length
799
x-amz-id-2
PZFUgfh0YdpSSOIGlhVRlX9C1re9mcWm34yPJh9TkjO3Rn4M3BLYzThywdiKii3q2wx4FO/t1eA=
hmi-registration-ui.vendor.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
356 KB
356 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.162.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
6f6380177618c6862586a5621d5b0e07217ab0ccdacd0a2a1a53b86f21b9ed5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:53 GMT
Last-Modified
Thu, 01 Aug 2019 16:14:19 GMT
Server
AmazonS3
x-amz-request-id
C12CD9632B2BF8E8
ETag
"f011bd848f5dd264858501030276d904"
Content-Type
application/javascript
x-amz-version-id
6ZmdlJsSh9vkAhXcUCtt_BjoAU.kCB7l
Accept-Ranges
bytes
Content-Length
364336
x-amz-id-2
H3rL4Rzgrmo1bEWK0We0O3U/aXuD0iYyNqZr0SoembCgwYywLmavyGsqjfzxk72KkzOrj0SfOEA=
hmi-registration-ui.bundle.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
1 MB
1 MB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.162.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e3741cb5d52b90eaf48d32a7e5413650b4cb1a47aeff1f149e5f99cd59a09ea2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:53 GMT
Last-Modified
Thu, 01 Aug 2019 16:14:19 GMT
Server
AmazonS3
x-amz-request-id
D36D0B080A7DC803
ETag
"6f0a7385fc124b239184087c1a7638d5"
Content-Type
application/javascript
x-amz-version-id
wCa6VPmHJ93WvGHO4M908GRyHC2vuvjV
Accept-Ranges
bytes
Content-Length
1272648
x-amz-id-2
Jj3v5qIUUIEZGw1+ekCu3Y6ivo6Rd9pWDEXLWBGbxejwLoG5wBBhdaCbl3Z/ToDixlhZ76Y/bnA=
autosuggest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/
4 KB
2 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/autosuggest.min.js?ver=3.0.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
c93e697d8038c51fe0e5002d6ff046cfe3497e03a47c302684292b3f1eeb6c46

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-117d"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
frontend.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
145 KB
39 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
64a0cd363010895321d3015d8c7973aa9ee24623e6ba363e76d1be39b09f4bd5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Thu, 15 Aug 2019 13:03:33 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d555825-245d3"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
iab.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
8 KB
2 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1565874213
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
ae1eff31eff9623af795e27413312563c498759622b7c17ede94ed31b5594e89

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Thu, 15 Aug 2019 13:03:33 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d555825-1ecd"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
wp-embed.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/
1 KB
1003 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/wp-embed.min.js?ver=5.2.2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
last-modified
Thu, 30 Aug 2018 12:40:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5b87e5ba-57b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
integrator.js
adservice.google.de/adsid/
109 B
476 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
476 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 26 Aug 2019 05:12:51 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
pubads_impl_2019081901.js
securepubads.g.doubleclick.net/gpt/
157 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
d13db8b95f4bea4d1f6acba9dd08e9e026540e8bf28b19133c5e85d42b953b39
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 13:05:42 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
59487
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:52 GMT
7341.js
script.crazyegg.com/pages/scripts/0034/
88 KB
28 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0034/7341.js?435221
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
9657fb8a0a588adb91904cc27ad6112de087dfc6d0f606e3a0581ab3f11f820d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
cf-cache-status
HIT
age
2789
cf-polished
origSize=90069
x-cache
Hit from cloudfront
status
200
content-encoding
gzip
last-modified
Tue, 20 Aug 2019 14:00:23 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
private, max-age=300
x-amz-cf-pop
VIE50-C1
cf-ray
50c3502f7cc3cbbc-VIE
x-amz-cf-id
J7QwyhXsonf7d1177jXu8wtqkhS-sLVbVCFHj43GjSOMEZA2Us7R6Q==
cf-bgj
minify
analytics.js
www.google-analytics.com/
43 KB
18 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
1756
date
Mon, 26 Aug 2019 04:43:36 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
17803
expires
Mon, 26 Aug 2019 06:43:36 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1566796371983&ns_c=UTF-8&c8=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%2...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566796371983&ns_c=UTF-8&c8=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566796371983&ns_c=UTF-8&c8=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&c9=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:52 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566796371983&ns_c=UTF-8&c8=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&c9=
Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:52 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
src.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/
33 KB
10 KB
Other
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811

Request headers

Sec-Fetch-Mode
same-origin
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-8317"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=2592000
S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wXiWtFCc.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 08:46:06 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:55 GMT
server
sffe
age
73606
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14044
x-xss-protection
0
expires
Mon, 24 Aug 2020 08:46:06 GMT
chevron-right-white.svg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/
190 B
399 B
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/chevron-right-white.svg
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1564580337
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-be"
vary
Accept-Encoding
x-cache
HIT
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=2592000
BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 23 Aug 2019 02:58:25 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:27:03 GMT
server
sffe
age
267267
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
11388
x-xss-protection
0
expires
Sat, 22 Aug 2020 02:58:25 GMT
BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 23 Aug 2019 10:54:36 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:19:23 GMT
server
sffe
age
238696
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
11272
x-xss-protection
0
expires
Sat, 22 Aug 2020 10:54:36 GMT
S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 21 Aug 2019 21:19:20 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:54 GMT
server
sffe
age
374012
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14176
x-xss-protection
0
expires
Thu, 20 Aug 2020 21:19:20 GMT
atrk.js
d31qbv1cthcecs.cloudfront.net/
4 KB
2 KB
Script
General
Full URL
https://d31qbv1cthcecs.cloudfront.net/atrk.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.5 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-5.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
90451ba3e82cd9db02f0ca76bd45d0ab5ef7e90a49da4215903cb7f08471e2e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 14 Jun 2019 21:28:30 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Sat, 16 Mar 2019 16:01:33 GMT
Server
AmazonS3
Age
6248663
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
text/javascript
Via
1.1 21da0a66bafe2c8de8be4a4d8039346b.cloudfront.net (CloudFront)
Cache-Control
max-age=26920000
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA6-C1
X-Amz-Cf-Id
KGbII9AWZ9QQUryK16Q-oMybq4qzgfGaOhajUr5KnZn5V9EGNl53qQ==
gg.js
sb.scorecardresearch.com/rs/pt/
2 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:52 GMT
Content-Encoding
gzip
Connection
keep-alive
X-N
S
Content-Length
1246
Vary
Accept-Encoding
Content-Type
application/x-javascript
fbevents.js
connect.facebook.net/en_US/
88 KB
24 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
f15f778cd39043a166a29f654b1191bc6fbf8043a8cc3477c42764b14b919dec
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
23404
x-xss-protection
0
pragma
public
x-fb-debug
6e2bPOGG6StWZdqXU5UeaO5IUUQbPDn0llnegWkUfhjJQ2Ytxrya4bpvRYT5ZChdqaeUsgVjGLTGNygxAFGNpQ==
x-fb-trip-id
365799557
x-frame-options
DENY
date
Mon, 26 Aug 2019 05:12:52 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
i
sp.sitomobile.com/
Redirect Chain
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://mt.sitomobile.com/sync/tacb?exid=28119540-c7c0-11e9-9128-aa3756790559&aid=136&sid=hmm&val=12
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5...
43 B
388 B
Script
General
Full URL
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.225.65.223 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-65-223.compute-1.amazonaws.com
Software
Apache-Coyote/1.1 /
Resource Hash
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:53 GMT
Server
Apache-Coyote/1.1
Connection
keep-alive
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR NID PSA OUR IND COM NAV STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Date
Mon, 26 Aug 2019 05:12:53 GMT
Server
nginx/1.12.1
X-Powered-By
Express
Vary
Accept
Content-Type
text/plain; charset=utf-8
Location
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Connection
keep-alive
Content-Length
972
up_loader.1.1.0.js
js.adsrvr.org/
6 KB
2 KB
Script
General
Full URL
https://js.adsrvr.org/up_loader.1.1.0.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.255.55 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-255-55.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 25 Aug 2019 19:02:41 GMT
Content-Encoding
gzip
Last-Modified
Wed, 17 Jul 2019 18:26:10 GMT
Server
AmazonS3
Age
46971
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 c1fb60e38be5022a78e4b52bedded7c2.cloudfront.net (CloudFront)
Connection
keep-alive
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA6-C1
X-Amz-Cf-Id
Ax_xDA9VqgDoJtcYgPvTbZiB095bxoNUbe6ofacr42UFA1BUSIYXiQ==
js
www.google-analytics.com/gtm/
56 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-T8P2ZZ9&t=gtm1&cid=1731879218.1566796372
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
2b0cf0b94f5307f8b64f855263d5de010fb74353be7a433cc5a59561cdfaaa1f
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
21537
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:52 GMT
96ac8580a54c3864c4ba15ff4a38efdcb7084985.js
mpct1.maropost.com/accounts/1323/websites/5/track/
4 KB
3 KB
Script
General
Full URL
https://mpct1.maropost.com/accounts/1323/websites/5/track/96ac8580a54c3864c4ba15ff4a38efdcb7084985.js?contact_id=2303653&campaign_id=65762&title=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&url=https%3A%2F%2Fempr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&
Requested by
Host: content.maropost.com
URL: https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.238.92.4 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
4.92.238.35.bc.googleusercontent.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.4 / Phusion Passenger 5.3.4
Resource Hash
394db2da5efaceff8eeef044b80291c0c7c0c6d5dfe35e39d0d81e7fcd680a5f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:52 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-Powered-By
Phusion Passenger 5.3.4
Transfer-Encoding
chunked
Status
200 OK
Connection
keep-alive
Vary
Accept-Encoding
X-XSS-Protection
1; mode=block
X-Request-Id
9d6d3174-2804-4987-98fa-ca7b6ee9d8c2
X-Runtime
0.035559
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
ETag
W/"391ad37dbbe9cfddfc8dafcd814bcbc6"
X-Frame-Options
SAMEORIGIN
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=0, private, must-revalidate
lio.js
c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/
45 KB
11 KB
Script
General
Full URL
https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
50c350301f92cbc4-VIE
date
Mon, 26 Aug 2019 05:12:52 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
914
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Mon, 26 Aug 2019 07:12:52 GMT
most-widget
www.empr.com/wp-json/haymarket/v1/
4 KB
2 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/most-widget?id=most-5
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
93207da1092d103352d9b4a9234709f727472e17949513f970a7b69b96cb7177
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 6
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
wpe-backend
apache
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
122567
www.empr.com/wp-json/haymarket/v1/infinite-scroll/
11 KB
3 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/infinite-scroll/122567
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
9b2559ee95222332331b9ccf27a50e02e3edb138cce8f1a65e839facaa1d54ba
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 1
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
wpe-backend
apache
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
partial-login
www.empr.com/wp-json/haymarket/v1/
634 B
854 B
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/partial-login?subid=&subemail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad16911f49d3e72d789bfe438841576129e86d69f42bcaddf489d3523ed69951
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 9
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
wpe-backend
apache
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
/
accounts.haymarketmedia.com/sso/check/
45 B
439 B
XHR
General
Full URL
https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.192.84.248 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-192-84-248.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
x-aspnetmvc-version
4.0
server
Microsoft-IIS/8.5
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.empr.com
cache-control
private
access-control-allow-credentials
true
content-length
45
1073716492693685
connect.facebook.net/signals/config/
307 KB
78 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1073716492693685?v=2.9.4&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;report-uri https://www.facebook.com/csp/reporting/
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
79754
x-xss-protection
0
pragma
public
x-fb-debug
EB5s2qyvO9EqK4q7kyZqW/qWdsy983nk/x8QEWd8mUOCqiFrNCtT0YG5+eiNgAo/TNEBoPV92NPSB6+gNMUawQ==
x-fb-trip-id
365799557
x-frame-options
DENY
date
Mon, 26 Aug 2019 05:12:52 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;report-uri https://www.facebook.com/csp/reporting/
expires
Sat, 01 Jan 2000 00:00:00 GMT
beacon.js
www.medtargetsystem.com/javascript/
177 KB
52 KB
Script
General
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
f19fa5a10f8202dd8791086c2bc5fc7f56d9a202d46cf8a99d36e914498614f2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Content-Encoding
gzip
Last-Modified
Thu, 15 Aug 2019 18:27:18 GMT
Server
Apache/2.4.7 (Ubuntu)
ETag
"2c33b-5902c060c8d80-gzip"
Vary
X-Forwarded-Proto,Accept-Encoding
Content-Type
application/javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
52863
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
995 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 04:59:16 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
816
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
856
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:59:16 GMT
tag.aspx
ml314.com/
26 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?2672019
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
7d655e8cd62ba58d86b3bc9c8e1e04a76506a4dfc852c3b3813deb0aef284548

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Content-Encoding
gzip
Last-Modified
Mon, 26 Aug 2019 05:03:03 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=85808
Connection
keep-alive
Content-Length
11933
Expires
Tue, 27 Aug 2019 05:03:03 GMT
atrk.gif
certify.alexametrics.com/
43 B
551 B
Image
General
Full URL
https://certify.alexametrics.com/atrk.gif?frame_height=1200&frame_width=1600&iframe=0&title=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&time=1566796372505&time_zone_offset=-120&screen_params=1600x1200x24&java_enabled=0&cookie_enabled=1&ref_url=&host_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&random_number=8894279465&sess_cookie=966a75b916ccc575a19b93e0c41&sess_cookie_flag=1&user_cookie=966a75b916ccc575a19b93e0c41&user_cookie_flag=1&dynamic=true&domain=empr.com&account=gujPp1NErb205V&jsv=20130128&user_lang=en-US
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.69 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-69.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 01:59:18 GMT
Via
1.1 507b5edb20d0e1a0b73c8687f53defa9.cloudfront.net (CloudFront)
Last-Modified
Mon, 17 Jan 2011 20:41:40 GMT
Server
AmazonS3
Age
19741
ETag
"221d8352905f2c38b3cb2bd191d630b0"
X-Cache
Hit from cloudfront
Content-Type
image/gif
Connection
keep-alive
Accept-Ranges
bytes
X-Amz-Cf-Pop
FRA6-C1
x-amz-meta-alexa-last-modified
20110117123941
Content-Length
43
X-Amz-Cf-Id
Tb2dydrsqnKsRx0GU1FWkrAv4LvgzHBnnDgZ3-lTjev6Owj81UTZvA==
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=62581692&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-fai...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_gid=963010317.1566796372&gjid=4173117&_v=j79&z=1378880558
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_v=j79&z=1378880558
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_v=j79&z=1378880558&slf_rd=1&random=2276880429
42 B
374 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_v=j79&z=1378880558&slf_rd=1&random=2276880429
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:52 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:52 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=733643057&_v=j79&z=1378880558&slf_rd=1&random=2276880429
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
inferredEvents.js
connect.facebook.net/signals/plugins/
1 KB
898 B
Script
General
Full URL
https://connect.facebook.net/signals/plugins/inferredEvents.js?v=2.9.4
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
cd1c301a8e7960a1786e2a959226b0b78b56dbea284bd114265f1662d6ca280e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
772
x-xss-protection
0
pragma
public
x-fb-debug
SW0shLR+F/vhStNzqUUIlvNCrZMM2C/1S36YmLWH+W4HKsgkMApXm9Ozdp/glEEwUxxTbwAmGBND02IAyX0Tog==
x-fb-trip-id
365799557
x-frame-options
DENY
date
Mon, 26 Aug 2019 05:12:52 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
expires
Sat, 01 Jan 2000 00:00:00 GMT
io.min.js
c.lytics.io/static/v2/
13 KB
6 KB
Script
General
Full URL
https://c.lytics.io/static/v2/io.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
b2435070f04e40c2666a729a016c60355b2025c969c3b7857489b7c8b2755bc2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
50c350305fe5cbc4-VIE
date
Mon, 26 Aug 2019 05:12:52 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 26 Jun 2019 19:48:45 GMT
server
cloudflare
age
4625
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Mon, 26 Aug 2019 07:12:52 GMT
/
www.facebook.com/tr/
44 B
323 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1073716492693685&ev=PageView&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&rl=&if=false&ts=1566796372534&sw=1600&sh=1200&v=2.9.4&r=stable&ec=0&o=30&fbp=fb.1.1566796372533.1929976899&it=1566796372474&coo=false&rqm=GET
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:52 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
content-length
44
expires
Mon, 26 Aug 2019 05:12:52 GMT
4
c.lytics.io/cid/
76 B
331 B
Script
General
Full URL
https://c.lytics.io/cid/4?callback=jQuery11240476362865880795_1566796371902&_=1566796371903
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0686f5495628a74f57776eeebe84949e2b20c52327db3cf6469c18ed2dcf48f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
50c350307813cbc4-VIE
pragma
no-cache
date
Mon, 26 Aug 2019 05:12:52 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
content-encoding
br
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
expires
0
74508fc76dca5391fdb5ee5585bcc1af
api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/ Frame 5FCB
0
0
Document
General
Full URL
https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/74508fc76dca5391fdb5ee5585bcc1af?segments=true&mergestate=true&ts=1566796372700
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d /
Resource Hash

Request headers

:method
GET
:authority
api.lytics.io
:scheme
https
:path
/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/74508fc76dca5391fdb5ee5585bcc1af?segments=true&mergestate=true&ts=1566796372700
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
accept-encoding
gzip, deflate, br
cookie
__cfduid=d96cbb56658a5fd4d78062f9aa0215dd91566796372; seerid=74508fc76dca5391fdb5ee5585bcc1af
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653

Response headers

status
200
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
access-control-allow-methods
GET
access-control-allow-origin
content-encoding
gzip
content-type
text/html
server
lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d
date
Mon, 26 Aug 2019 05:12:52 GMT
content-length
294
via
1.1 google
alt-svc
clear
/
www.facebook.com/tr/ Frame 3E57
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
12790
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
accept-encoding
gzip, deflate, br
cookie
fr=04N53UqcDmLh1WTXh..BdY2pU...1.0.BdY2pU.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Mon, 26 Aug 2019 05:12:53 GMT
/
www.facebook.com/tr/ Frame 9A78
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3712
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
accept-encoding
gzip, deflate, br
cookie
fr=04N53UqcDmLh1WTXh..BdY2pU...1.0.BdY2pU.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Mon, 26 Aug 2019 05:12:53 GMT
pathfora.min.js
c.lytics.io/static/
98 KB
20 KB
Script
General
Full URL
https://c.lytics.io/static/pathfora.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
50c35034af08cbc4-VIE
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
4259
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Mon, 26 Aug 2019 07:12:53 GMT
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?_ts=1566796373112&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_e=pv&utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&_sesstart=1&_tz=2&_ul=en-US&_sz=1600x1200&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034bf48cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?publicationId=13&channel=home&pagetype=post&tags=cardiovascular%20disease%2Cchf%20and%20arrhythmias%2Cdiabetes%2Cendocrine%20disorders&categories=news&pagename=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial&author=Diana%20Ernst%2C%20RPh&section=home%3Anews%3Adapagliflozin%20reduces%20risk%20of%20cv%20death%2C%20hospital%20admission%20in%20heart%20failure%20trial&email=nguyentt%40sutterhealth.org&user_id=0&cpn=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&login=nguyentt%40sutterhealth.org&userstate=CA&userspecialty=&userprofession=Physician&_ts=1566796373114&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf4acbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1566796371760&event=gtm.js&gtm.uniqueEventId=15&_ts=1566796373115&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf4ccbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.AdBlocking=&_ts=1566796373116&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf4ecbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NHTFlag=false&_ts=1566796373117&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf50cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleId=122567%3A0&_ts=1566796373119&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf51cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleType=News&_ts=1566796373120&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf52cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.MetaData=&_ts=1566796373121&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf53cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Type=post&_ts=1566796373122&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf54cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.ScrollDepth=&_ts=1566796373124&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf55cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.cmeActivityId=&_ts=1566796373125&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf57cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PrintSource=&_ts=1566796373126&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034cf58cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.SEOScore=&_ts=1566796373128&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df7ecbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.Prefix=omn&_ts=1566796373129&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df80cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.PublicationId=13&_ts=1566796373131&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df82cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Author=Diana%20Ernst%2C%20RPh&_ts=1566796373132&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df83cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.PremiumMonograph=&_ts=1566796373133&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df85cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.Geolocation=&_ts=1566796373135&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df87cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Activity.Name=&_ts=1566796373136&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df88cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GenericEvents=&_ts=1566796373138&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df89cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.CurrencyCode=&_ts=1566796373139&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df8acbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.OrderId=&_ts=1566796373141&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df8bcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Drug.CompanyName=&_ts=1566796373142&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df8ccbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.IsPremiumMonograph=false&_ts=1566796373144&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df8dcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GatingType=post%3Anone&_ts=1566796373145&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df8ecbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Company=&_ts=1566796373146&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df8fcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Discipline=&_ts=1566796373147&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df90cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Asset=&_ts=1566796373148&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df91cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
231 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PublishDate=2019-08-21&_ts=1566796373149&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df92cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Curation=false&_ts=1566796373151&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df93cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.WordCount=267&_ts=1566796373152&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df95cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.CreditType=&_ts=1566796373154&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df97cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.ActivityResult=&_ts=1566796373155&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df98cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.NumberofAdCalls=9&_ts=1566796373157&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df99cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.ProductsInCart=&_ts=1566796373158&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df9acbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section1=home&_ts=1566796373160&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df9bcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section2=home%3Anews&_ts=1566796373161&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df9dcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section3=home%3Anews%3Adapagliflozin%20reduces%20risk%20of%20cv%20death%2C%20hospital%20admission%20in%20heart%20failure%20trial&_ts=1566796373163&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df9ecbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section4=&_ts=1566796373165&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034df9fcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Tags=cardiovascular%20disease%2Cchf%20and%20arrhythmias%2Cdiabetes%2Cendocrine%20disorders&_ts=1566796373166&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa0cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Categories=news&_ts=1566796373168&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa1cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.LoggedIn=false&_ts=1566796373170&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa4cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Login=&_ts=1566796373171&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa5cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SocSSN=&_ts=1566796373173&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa6cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SSO=3&_ts=1566796373175&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa7cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubscriberId=0&_ts=1566796373176&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa8cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
96 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Source=&_ts=1566796373178&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfa9cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Profession=Physician&_ts=1566796373179&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfaacbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Specialty=&_ts=1566796373180&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfabcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubProfession=&_ts=1566796373182&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfaccbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubSpecialty=&_ts=1566796373183&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfadcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.JobTitle=&_ts=1566796373185&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfaecbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CampaignCodes=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&_ts=1566796373186&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfafcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
117 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Country=&_ts=1566796373188&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfb1cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Company=&_ts=1566796373189&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfb2cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CompanySize=&_ts=1566796373191&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfb3cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsHaymarket=false&_ts=1566796373192&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfb4cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsTracked=true&_ts=1566796373193&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfb6cbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsFromAim=false&_ts=1566796373195&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfbbcbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
166 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NpiNumber=1619909975&_ts=1566796373196&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfbccbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1566796372438&event=gtm.js&gtm.uniqueEventId=3&_ts=1566796373197&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&_uid=74508fc76dca5391fdb5ee5585bcc1af&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
50c35034dfbecbc4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
css
fonts.googleapis.com/
1 KB
477 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,900
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 26 Aug 2019 05:12:53 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Mon, 26 Aug 2019 05:12:53 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:53 GMT
truncated
/
5 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.4.48.124 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-4-48-124.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.4.48.124 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-4-48-124.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
truncated
/
24 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/gif
truncated
/
82 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml
74508fc76dca5391fdb5ee5585bcc1af
api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/
187 KB
34 KB
XHR
General
Full URL
https://api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/74508fc76dca5391fdb5ee5585bcc1af?limit=30&contentsegment=ee9fe9a51cf2f1774e42f33abc9ca99c&shuffle=true
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d /
Resource Hash
af45e9ab0aa4ee5ede418690988f533b3e6d1223aacce6624bb66d28793b6251

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
content-encoding
gzip
server
lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
status
200
access-control-allow-methods
GET
content-type
application/json
access-control-allow-origin
https://www.empr.com
alt-svc
clear
via
1.1 google
pathfora.min.css
c.lytics.io/static/
20 KB
3 KB
Stylesheet
General
Full URL
https://c.lytics.io/static/pathfora.min.css
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/static/pathfora.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
50c3503588c4cbc4-VIE
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
4258
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Mon, 26 Aug 2019 07:12:53 GMT
config.js
c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/
91 KB
10 KB
Script
General
Full URL
https://c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/config.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
5ff91653d02d048ed74ad7a92e1aa3545b383e23333248405b6d1819f14be72b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
50c3503588c6cbc4-VIE
date
Mon, 26 Aug 2019 05:12:53 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
926
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Mon, 26 Aug 2019 07:12:53 GMT
ads
securepubads.g.doubleclick.net/gampad/
4 KB
3 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2670437118291279&correlator=1271144652985695&output=ldjh&callback=googletag.impl.pubads.callbackProxy1&impl=fif&adsid=NT&eid=21062414%2C21062724%2C21062886%2C21063817&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2FOOP_prestitial&sz=1x1&ists=1&scp=pos%3DOOP_prestitial&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D122567%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DCardiovascular_Disease%252CCHF_and_Arrhythmias%252CDiabetes%252CEndocrine_Disorders%26atype%3DNews%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1566796373&dt=1566796373555&dlt=1566796371753&idt=784&frm=20&biw=1585&bih=1200&oid=3&adx=0&ady=3524&adk=1518026067&uci=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&dssz=78&icsg=38070606888960&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1585x3525&msz=1585x1&blev=1&bisch=1&ga_vid=1731879218.1566796372&ga_sid=1566796374&ga_hid=62581692&fws=4&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
2f63e435ec7fdf67b62d37f7543608ef888fb5771fc880acc94fa749e35b06a5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
2090
x-xss-protection
0
google-lineitem-id
132788185
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138274708445
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019081901.js
securepubads.g.doubleclick.net/gpt/
66 KB
25 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
a9f4ae6b4905f74dfe7fb7fce1fc8ee328d1d1d085a783257fed1f970c0d9b72
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 13:05:42 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
25389
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:53 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0

registration-profession
subapi.haymarketmedia.com/
589 B
876 B
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.4.48.124 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-4-48-124.compute-1.amazonaws.com
Software
/ Express
Resource Hash
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.4.48.124 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-4-48-124.compute-1.amazonaws.com
Software
/ Express
Resource Hash
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
truncated
/
88 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml;charset=utf-8
universal-tag.js
ads.spotible.com/tag/ Frame 4642
4 KB
2 KB
Script
General
Full URL
https://ads.spotible.com/tag/universal-tag.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
8a846df9c01f4d8d8b6e82c6e505069104280430b3b05d94a13a5b99d7c854aa

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:54 GMT
Content-Encoding
gzip
ETag
"5c736e518f66ceaaee6badc00016e1a5"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=3600
Connection
keep-alive
Content-Length
1767
truncated
/ Frame 4642
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f7ed838237ea2501ebae9e27236e22a9e57303dc65bfa03feaa5c228ee410f6b

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
osd.js
www.googletagservices.com/activeview/js/current/
75 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f876042041fbf3fd3ca277c5bc8d70ae5a82769a34e186a2b7cb3b7357c52c77
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:53 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1566558908912117"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28364
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:53 GMT
gen_204
pagead2.googlesyndication.com/pagead/
0
219 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=gpt_sz&r=1x1&w=1&h=1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:53 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:da00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Mon, 26 Aug 2019 05:12:54 GMT
via
1.1 c26b8e74df43cd99786e716221463d0c.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
28a0b6bd-c7c0-11e9-b870-338f39c2be28
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d636a56-cfe2789a27f40f0ef85f4c54;Sampled=0
x-amz-apigw-id
fA2NcEe8IAMFjAw=
content-length
2
x-amz-cf-id
Rz6tJM8UwkC3DEmoavYVAitENVrcR0G0dgA6DFyIhKla8xyUDFgMYA==
Kidney-renal-blood-cells.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/
211 KB
212 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/Kidney-renal-blood-cells.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
9469f1c595636ba25b19f8df2801fc924192cc21f441204970d7b28c1286bbcc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Sat, 04 May 2019 07:11:31 GMT
server
nginx
etag
"a5820f9644471b4e8a31fe519433fbf4"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
216245
expires
Wed, 25 Sep 2019 05:12:54 GMT
hemophiliass515341795_1205710.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
145 KB
145 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hemophiliass515341795_1205710.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ff22b4a32c2825038a9d960fd1228005fd8728bd64343b555a0ce7f17b1d2ed4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 23:56:57 GMT
server
nginx
etag
"e08720af679ed6a713965a221c4f9785"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
148047
expires
Wed, 25 Sep 2019 05:12:54 GMT
psoriaticarthritischalkboard_1274840.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
43 KB
43 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/psoriaticarthritischalkboard_1274840.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
f8d01ec910b326a38c827a7ad81338b72df1e3e51602f72d108ecaeff2d83160

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 21:58:03 GMT
server
nginx
etag
"917b47dbe027ae6bbc98084871e68f0b"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
44009
expires
Wed, 25 Sep 2019 05:12:54 GMT
hydrochlorothiazide125mg100_1478685.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
8 KB
8 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hydrochlorothiazide125mg100_1478685.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
fa59ac0717445513b3e86fa270a5459f79af3e76f658270e5ad6d84cefa1b67e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 21:47:31 GMT
server
nginx
etag
"4b07fb7ea5eb4361cdad132d50128acd"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
8281
expires
Wed, 25 Sep 2019 05:12:54 GMT
stjohnswortns_1025667.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
120 KB
120 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/stjohnswortns_1025667.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
4029685f0104ac98118094b6adbe2ca7f8241025a320111d2647d0a867626d8a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 19:32:42 GMT
server
nginx
etag
"7f792fc2901115c21d72bcb93cff1c4c"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
122385
expires
Wed, 25 Sep 2019 05:12:54 GMT
childrenplayingns_950763.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
223 KB
223 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/childrenplayingns_950763.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
1db536baa18c7d63d8b102925a272275ba864d3322402884c8ea91ddd5a3c341

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 21:55:37 GMT
server
nginx
etag
"2aaef43ea1b0278868486248e260b2e2"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
227932
expires
Wed, 25 Sep 2019 05:12:54 GMT
breakthrough_1002211.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
168 KB
169 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/breakthrough_1002211.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8c2303690ee0ee206f20c1f70c7b5eb29e1d592cebacb1cac0b3c7b3669e95ca

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 21:42:13 GMT
server
nginx
etag
"45112d9354d777c4d33b6c67d062a807"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
172410
expires
Wed, 25 Sep 2019 05:12:54 GMT
481542otezla30mgsinglens_963850.png
www.empr.com/wp-content/uploads/sites/7/2018/12/
139 KB
139 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/481542otezla30mgsinglens_963850.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
643785cbdf05e8cbc1f03dcb412c95c14bfb8eb067980c5bd7c4d7d8b805b74a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 23:50:03 GMT
server
nginx
etag
"61a590d2eb564fad1e3ea49dbd8cadce"
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
142188
expires
Wed, 25 Sep 2019 05:12:54 GMT
rheumatoidarthritisfingerss_1338086.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
20 KB
20 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/rheumatoidarthritisfingerss_1338086.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
e7286d04cf4a45fbb96f9ff861edfcaf92e125ea02f4e5dc6a9282901f693b28

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 09:08:31 GMT
server
nginx
etag
"98a99549b3964ff4ef9e6419f4e6874f"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
20214
expires
Wed, 25 Sep 2019 05:12:54 GMT
airplaintakingoff_1017059.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
137 KB
137 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/airplaintakingoff_1017059.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
b494e6c104ae3e24d72e47c444c6d3b290ee92274d3949806c12a71dc3d002f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 23:45:45 GMT
server
nginx
etag
"ee5b5da6c2b456356cbe0e69d8b03755"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
139845
expires
Wed, 25 Sep 2019 05:12:54 GMT
Woman-taking-tablet-G-57158250.jpg
www.empr.com/wp-content/uploads/sites/7/2019/03/
24 KB
24 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/03/Woman-taking-tablet-G-57158250.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
fe4ee8cc9d0936f299bb1ebe179f27a4cedef239fac660cdb6e8a7827b8e85bd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 09:02:15 GMT
server
nginx
etag
"cbd04b708c58505a8554d7c0baa3ebed"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
24504
expires
Wed, 25 Sep 2019 05:12:54 GMT
prayerg674499213_1490567.jpg
www.renalandurologynews.com/wp-content/uploads/sites/22/2018/10/
9 KB
9 KB
Image
General
Full URL
https://www.renalandurologynews.com/wp-content/uploads/sites/22/2018/10/prayerg674499213_1490567.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
1ba44d3a780525ed61938485d549740a3b649d8af5f4e8d7ba1298edf5ab4dd7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Tue, 30 Jul 2019 07:12:02 GMT
server
nginx
etag
"537524eccd8417c176cef91a26a9db77"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
9309
expires
Wed, 25 Sep 2019 05:12:54 GMT
fdaro_1143890.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
76 KB
76 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/fdaro_1143890.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7e357c3c78fcab868c0e3206231cb39bedf6f2edbc8db58318ff53b408acfa11

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Thu, 21 Mar 2019 02:12:09 GMT
server
nginx
etag
"d526f8cda3e9bcc43b0c7a6cad2a00d0"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
77799
expires
Wed, 25 Sep 2019 05:12:54 GMT
heartattackg530779559_1461739.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
21 KB
22 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/heartattackg530779559_1461739.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
51acd6cae9a2c501f05bdfaa4d52c131e4297365de18b044d92b2cc06c2bcc9e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 21:49:16 GMT
server
nginx
etag
"ee7d8347e3728bd5da4c4ec521d76a55"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
21829
expires
Wed, 25 Sep 2019 05:12:54 GMT
headachemigraineillustration_1290665.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
22 KB
23 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/headachemigraineillustration_1290665.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
635994bacaaafcf5296ca204df7739d714b94ad861f7156c0d3e98d5353de747

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 22:03:06 GMT
server
nginx
etag
"2f2ca0ad618d7044e38fea32bab1994d"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
22898
expires
Wed, 25 Sep 2019 05:12:54 GMT
gonorrheag758308325_1504215.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
34 KB
35 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/gonorrheag758308325_1504215.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2703f44ce0b0236ef2544fa6c208a1e443f0784445cbc4ddd1fdaa336295d12b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 09:14:42 GMT
server
nginx
etag
"5518efa00d4f33f2ebceae95dbe927d5"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
35253
expires
Wed, 25 Sep 2019 05:12:54 GMT
dupixentdupilumabinjsanofi_1189941.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
106 KB
107 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/dupixentdupilumabinjsanofi_1189941.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
0bf574a45ef06dba35857ee315e610bfa4feec4fa3063d2213dca5d96d1e500f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 21:46:45 GMT
server
nginx
etag
"088a44e7fe3e3218ddc8c9a6eaa315f8"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
109024
expires
Wed, 25 Sep 2019 05:12:54 GMT
hepatitisbss531853195_1353359.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
28 KB
28 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hepatitisbss531853195_1353359.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
65f2cba11d7a8fb4e042413fdcc6fee12e8723c6ae51bf120b49d7a429178a2e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 23:54:35 GMT
server
nginx
etag
"cdc768ed36bc7cd647d98f86f71da777"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
28834
expires
Wed, 25 Sep 2019 05:12:54 GMT
lungcancer2_1376266.jpg
media.empr.com/images/2018/02/20/
167 KB
168 KB
Image
General
Full URL
https://media.empr.com/images/2018/02/20/lungcancer2_1376266.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.36 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-36.fra6.r.cloudfront.net
Software
Microsoft-IIS/8.5 /
Resource Hash
a0761809c73e189d660329b14a3d67b4ed30f0666b226feb844e17eb91c852bb

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 05 May 2019 06:58:15 GMT
via
1.1 7ce1191b390045e05b9cc74f7514b77b.cloudfront.net (CloudFront)
age
9756804
x-cache
Hit from cloudfront
status
200
content-length
171071
last-modified
Tue, 20 Feb 2018 19:18:00 GMT
server
Microsoft-IIS/8.5
etag
"2ab1fb857faad31:0"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
max-age=31536000
imagefrom
New-Image
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
x-amz-cf-id
hcrKbpjBuBPT3qdshMsT6Yy7ALYMG5ajcoIwc3XDRteai4eW5P_vPQ==
urinarytractinfectionuti_1197915.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
150 KB
151 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/urinarytractinfectionuti_1197915.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
78b9d63c8bb41310ea0a891534cebe975558cb83b22809a3febbca243939e910

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 19:50:44 GMT
server
nginx
etag
"b8937eb9932998fcb13c63cc7b8f28e9"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
153844
expires
Wed, 25 Sep 2019 05:12:54 GMT
heartanatomyss233628424_1182563.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
186 KB
187 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/heartanatomyss233628424_1182563.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
571f0d2fbc5d9e206f4493f5ba110a70b1c55077bc9110e8d8b5bcb115cb9140

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 09:16:15 GMT
server
nginx
etag
"d7925ae0238bfedb07e5d889271d9e81"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
190920
expires
Wed, 25 Sep 2019 05:12:54 GMT
castofbronchial1thenewen_1515093.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
76 KB
77 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/castofbronchial1thenewen_1515093.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
1a1b6a4acf4a97fc703b565202769abae62d5a59208b11c921d878e9d5817990

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 19:26:57 GMT
server
nginx
etag
"77249c652e596c1ff0596b67cb9ebe0b"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
78335
expires
Wed, 25 Sep 2019 05:12:54 GMT
livergraphicdiagnosticsss5_1207852.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
135 KB
135 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/livergraphicdiagnosticsss5_1207852.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
b3647092d3dbff1fcb9fa2a29831d7187aaa105135e08e49946b2c30f8d29a89

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 23:41:59 GMT
server
nginx
etag
"93741d95033d0f1de5fe4b00493dcfab"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
138240
expires
Wed, 25 Sep 2019 05:12:54 GMT
inveltyspackagenskala_1520295.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
13 KB
13 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/inveltyspackagenskala_1520295.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7b9025bc821fe7e035dba945260d61e17a43699d25d06392182e81d0d565e455

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 09:08:36 GMT
server
nginx
etag
"3f5e1c636a33868979996690f1b7b208"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
12912
expires
Wed, 25 Sep 2019 05:12:54 GMT
aspirinpillsss117314986_1185666.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
107 KB
107 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/aspirinpillsss117314986_1185666.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
65c55694e657b6b8b939f93844ac6452a2b0d3ed47306b0c9190db990c21093f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 19:56:54 GMT
server
nginx
etag
"ff6e6974c4a63e3d9ae05bd924ec5903"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
109408
expires
Wed, 25 Sep 2019 05:12:54 GMT
FDA-HQ-1.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/
44 KB
44 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/FDA-HQ-1.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3622b951ea76b210435cfe0389822bfbeb3c690133e6c6fd4724c335b594420a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Sun, 28 Apr 2019 07:11:12 GMT
server
nginx
etag
"281477ab9f7eb60e6b7d1f61e45fe582"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
45105
expires
Wed, 25 Sep 2019 05:12:54 GMT
psilocybinmagicmushroomns_978492.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
175 KB
175 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/psilocybinmagicmushroomns_978492.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
92957755d608d90013353d5141554c10d0a2d85e0f034563c442814f91a6b1d1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 19:41:08 GMT
server
nginx
etag
"eebbfb07e934d243b94f028232a657ca"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
178894
expires
Wed, 25 Sep 2019 05:12:54 GMT
hivvirusinbloodstreamss44_1263619.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
48 KB
48 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hivvirusinbloodstreamss44_1263619.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
0ff97369e0e399fa511f9b1535984b315e45747aa24135dc6a02977e0d3a6477

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Wed, 20 Mar 2019 19:38:17 GMT
server
nginx
etag
"5a11cc64987c4e5e14bc9361828a63c7"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
48685
expires
Wed, 25 Sep 2019 05:12:54 GMT
diabeteswordstethoscopess4_1161209.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
198 KB
198 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/diabeteswordstethoscopess4_1161209.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-225-154-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2a3c8fc442100be71fa62aecfe6c6db82d0074d9b5b982940fb96dc402afb703

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Mon, 26 Aug 2019 05:12:54 GMT
last-modified
Thu, 21 Mar 2019 02:16:44 GMT
server
nginx
etag
"5f22abd2a5ef67a3b2900b245acc55bf"
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
202699
expires
Wed, 25 Sep 2019 05:12:54 GMT
creative-delivery.js
ads.spotible.com/creative/bmMb/
58 KB
20 KB
Script
General
Full URL
https://ads.spotible.com/creative/bmMb/creative-delivery.js
Requested by
Host: ads.spotible.com
URL: https://ads.spotible.com/tag/universal-tag.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
2df541ba2dac12759f5cc36999736a318e366452d683593b713ca1a53d1e27e5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:54 GMT
Content-Encoding
gzip
ETag
"c1d949de721a6052e9634dc663595413"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
no-cache
Connection
keep-alive
Content-Length
19905
MPR-lightbox_640x480-july19_Q.gif
cdn1.spotible.com/hashed/a0bb68f349c5a16009bb7cf6d5bab3bb/
685 KB
686 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/a0bb68f349c5a16009bb7cf6d5bab3bb/MPR-lightbox_640x480-july19_Q.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.52 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-52.fra6.r.cloudfront.net
Software
/
Resource Hash
ad15e0951b55982ad0447c99a54cc497669f65c84ac6b12616891fec5f51223c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 02 Jul 2019 21:06:07 GMT
via
1.1 7ce1191b390045e05b9cc74f7514b77b.cloudfront.net (CloudFront)
age
426402
etag
"a0bb68f349c5a16009bb7cf6d5bab3bb"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
701058
x-amz-cf-id
WEKaZzlp5BwHgZwXyfu4cf-MXBDys8aC3Pv8I-zgac-QoG3YOdAnjg==
ads
securepubads.g.doubleclick.net/gampad/
19 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2670437118291279&correlator=1271144652985695&output=ldjh&callback=googletag.impl.pubads.callbackProxy2&impl=fif&adsid=NT&eid=21062414%2C21062724%2C21062886%2C21063817&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fleaderboard_top&sz=728x90&scp=pos%3Dleaderboard_top&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D122567%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DCardiovascular_Disease%252CCHF_and_Arrhythmias%252CDiabetes%252CEndocrine_Disorders%26atype%3DNews%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3De4e58f285fbd3edc%3AT%3D1566796373%3AS%3DALNI_MbOul24L40fPLl-tKj2Dw71dFpaIw&cookie_enabled=1&bc=31&abxe=1&lmt=1566796374&dt=1566796374385&dlt=1566796371753&idt=784&frm=20&biw=1585&bih=1200&oid=3&adx=193&ady=140&adk=2785330797&uci=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&dssz=81&icsg=152282377224192&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1200x-1&msz=1200x-1&blev=1&bisch=1&psts=Ci8I2d-oP-gB3bfCjoMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QI5Ov2IJ3OplQ&ga_vid=1731879218.1566796372&ga_sid=1566796374&ga_hid=62581692&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
438b2323483bd093803fe7fa6121f52326259e76f6b3510d8fffc66010f550b9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:54 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5716
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
116494032265
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame ECE4
0
75 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssoOUH3kge1_RIXeTsWEAfKbjuZZ4tmEw6dU8qOjCeNtT1I5UZXz36ZRBC8tSho4ZBnJKmcnMgKa6HvHIHjSY51AZn0dgGoGRbHyGPhqLSPxblWGIWGfTsWxQjGcRtRcJhzNsyTvweJPw4xSD4UtZnXLBnNM2JRCWdCvCmQZk6CP9kfs5FQGR4rqRWOFBlClYzZ1IWQL2aH9f6IT7qVVcTUGtOf1GVDu-TX32QtAVrEC0eR86CGvsIukiifyoYstpEUqDts9malHXvQ2g9FXay8OQ&sig=Cg0ArKJSzOWy6fCdKCVmEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 26 Aug 2019 05:12:54 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/ Frame ECE4
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 01:22:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
100236
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1054
x-xss-protection
0
server
cafe
etag
18205873578609640656
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 08 Sep 2019 01:22:18 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame ECE4
75 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
99019b305dcd9c03e496cf964097ae47afd65407cd9b26840e05d50560a41169
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1566558908912117"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28532
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:54 GMT
l
www.google.com/ads/measurement/ Frame ECE4
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRN2O56cHZ-IN_a9NZq8ZtebPHUzKiq8tLapymrBEGFW0se6FwgLRHJLwZS0ynwV7j_5ws1_5r0GVUrw5Mb3TJwOHnOUA
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame ECE4
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776212071&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=116494032265&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:e914:8d8d:e7fd:f63e Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
6b07a073906a8de114ba9c34d1883c735b8d0fee76c881929d7134dcbeed2ec0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:55 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
16232809971630760556
tpc.googlesyndication.com/simgad/ Frame ECE4
31 KB
31 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/16232809971630760556
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
dc613fc8436e087510e49e0277c163489f8b80c8013b8de6e3c66f813c8ce5bf
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 11:45:51 GMT
x-content-type-options
nosniff
age
62823
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
31641
x-xss-protection
0
last-modified
Thu, 02 Feb 2017 14:35:45 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 24 Aug 2020 11:45:51 GMT
ads
securepubads.g.doubleclick.net/gampad/
19 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2670437118291279&correlator=1271144652985695&output=ldjh&callback=googletag.impl.pubads.callbackProxy3&impl=fif&adsid=NT&eid=21062414%2C21062724%2C21062886%2C21063817&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_1&sz=300x250%7C300x600&scp=pos%3Dbox_1%26lid%3D132783265&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D122567%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DCardiovascular_Disease%252CCHF_and_Arrhythmias%252CDiabetes%252CEndocrine_Disorders%26atype%3DNews%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3De4e58f285fbd3edc%3AT%3D1566796373%3AS%3DALNI_MbOul24L40fPLl-tKj2Dw71dFpaIw&cookie_enabled=1&bc=31&abxe=1&lmt=1566796374&dt=1566796374620&dlt=1566796371753&idt=784&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=305&adk=204078694&uci=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&dssz=80&icsg=152282377224192&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&blev=1&bisch=1&psts=Ci8I2d-oP-gB3bfCjoMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QI5Ov2IJ3OplQ%2CCi8IobmoP-gBibvX_LEDggIVsbmAD9G59iGBw_Yh8e3PNOfA2o9R0QK8PKbCz_7s6g&ga_vid=1731879218.1566796372&ga_sid=1566796374&ga_hid=62581692&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
f21bb8fad8ff1729cf97fb2b3318e965e830bbfd2b23ebbe378205a317d240f5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:54 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5693
x-xss-protection
0
google-lineitem-id
5144421111
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138278274593
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame ECE4
216 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
25ccb000d0ab50ce96b43bd31cc2abd0a9cd0afabf029dae05acd06392095ecc

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
report
ads.spotible.com/creative/bmMb/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/bmMb/report?,1566796374,617001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!2,1,0
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:54 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
57 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsu_3lqj9MZaOxZZxu4y7FbrcVinzxM1jJLj8AdjjvR6ZBSSNOFjntPITuG4nYdMPABDqQOgQHU5uPze5Ex0KcEamo-VTNctdmjACwz5xwith61wrSobX5EAb7sw0cMO3xsC_JcwdyeVIQGJcbh92SKrQo8z4Vy4Di5Z_x8d97LA8dnZ3c32HpjqTc2FGa0JlIKgEJCmjC9alR0woBXY1i9EhOrFCzuluDuO88P3mgLsagxwo6U4glMETp52T1BFziTmP2Xcg5SOQuzXbcljlwE617XatkzSE4UxldcZi9HIHs0J5Lup4sOPL58WSg&sai=AMfl-YRoT_ObvnIWfeDmymVjSmq3Mh-cX-vwWv--7oy9PH5gcCKOPPv0OhjRQFQh28_UTwGvMBjBUpxKcIXGUp8O-MhJqwyj0XlDHuolcwS4Jw&sig=Cg0ArKJSzByVPY300bMmEAE&urlfix=1&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 26 Aug 2019 05:12:54 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
view
securepubads.g.doubleclick.net/pcs/ Frame 7AC4
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssi_NJmuTODU_jA09UzdTHzw35cQ1agTvxcSmT2zqIr2u5GMmtMNZPnqaQ9us89wxraZUJZU-qCFvv3HgVmQOqv5oCdWQJZMwkCtI_tGhSf1-6KnoA1hAQAFK24oiIM45-pja7nGQAfZPrNe4LXGk1pimroAIbTcIKJLhBcBd50pLFj2Pw835s0X32DdLGOXpWsHmjSdlze_GdIVECZxd4mlw29M1ksvX61AldNR142ohqWKynPPn8TUqd4jXU7OiWm2ugygEu_iA&sig=Cg0ArKJSzL0tycMarAYgEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 26 Aug 2019 05:12:54 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/ Frame 7AC4
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 01:22:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
100236
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1054
x-xss-protection
0
server
cafe
etag
18205873578609640656
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 08 Sep 2019 01:22:18 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 7AC4
75 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
99019b305dcd9c03e496cf964097ae47afd65407cd9b26840e05d50560a41169
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1566558908912117"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28532
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:54 GMT
l
www.google.com/ads/measurement/ Frame 7AC4
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRaVQa8W5nssbptmoAkzakJFtW_HqvNVkGXhHqPGOEAl8q46YbL89KeRRjDQ9N_-ctpMvWVHccnwmZlJdsU6tvfokiu3A
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 7AC4
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031401&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278274593&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:e914:8d8d:e7fd:f63e Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
3eda2a6e0b3a7c4f5c96407a6f5f6a53786d69a998ef40bd4993cf16ccfbda0f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:55 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
4489233149016687223
tpc.googlesyndication.com/simgad/ Frame 7AC4
41 KB
41 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/4489233149016687223
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f984c8e1978cf73d7c628f6d255ced232aab616cd77fcf720d5afb6b98fe4725
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 24 Aug 2019 15:07:56 GMT
x-content-type-options
nosniff
age
137098
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42317
x-xss-protection
0
last-modified
Wed, 07 Aug 2019 16:56:46 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 23 Aug 2020 15:07:56 GMT
ads
securepubads.g.doubleclick.net/gampad/
19 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2670437118291279&correlator=1271144652985695&output=ldjh&callback=googletag.impl.pubads.callbackProxy4&impl=fif&adsid=NT&eid=21062414%2C21062724%2C21062886%2C21063817&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_2&sz=300x250&scp=pos%3Dbox_2%26lid%3D132783265%2C5144421111&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D122567%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DCardiovascular_Disease%252CCHF_and_Arrhythmias%252CDiabetes%252CEndocrine_Disorders%26atype%3DNews%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3De4e58f285fbd3edc%3AT%3D1566796373%3AS%3DALNI_MbOul24L40fPLl-tKj2Dw71dFpaIw&cookie_enabled=1&bc=31&abxe=1&lmt=1566796374&dt=1566796374880&dlt=1566796371753&idt=784&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=826&adk=3917873969&uci=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&dssz=80&icsg=152282377224192&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x283&msz=300x250&blev=1&bisch=1&psts=CjAI98WGlRPoAaGMnJCDBIICFbG5gA_RufYhgcP2IfHtzzSpvc-PUdEC3YrcEXfHnCk%2CCi8I2d-oP-gB3bfCjoMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QI5Ov2IJ3OplQ%2CCi8IobmoP-gBibvX_LEDggIVsbmAD9G59iGBw_Yh8e3PNOfA2o9R0QK8PKbCz_7s6g&ga_vid=1731879218.1566796372&ga_sid=1566796374&ga_hid=62581692&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
71f52b4035a972a399f7f3c230e54b7d6fc837a839e3099a77481ba21aa971e0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:55 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5585
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
116494043065
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
365 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:da00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Mon, 26 Aug 2019 05:12:55 GMT
via
1.1 c26b8e74df43cd99786e716221463d0c.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
2933ce22-c7c0-11e9-801c-bbaffd3eb46a
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d636a57-208c0648dd5478c877b2c9e8;Sampled=0
x-amz-apigw-id
fA2NmHVTIAMF9GA=
content-length
2
x-amz-cf-id
4goNsoeWswiojET5qPy25aWxUgPNZ-DTc6eNU1gxPyOTFLz8WyCTyA==
truncated
/ Frame 7AC4
209 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
cf16318f63ae35c429ae870eba98f1ea581a68200daa2e12f92c6e349f64ba0a

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame DD22
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvBjhI2Wi5eCLaKXfsotoaM2JM_eQlOP3C11S1UCUEjdUegghyixWtvLf6gYzIxAh8jUP6KcosBnkERI_2loLKmjOO0sMeDgzFjgWi3Ew9rXVu1bAf8UvpY3P7yk4Igy0HwHkPGophCP9NeaYlYkZkh9I8IP8MKHZUdu-BQk8na7PtrRZLOUiyTzR8dBW1pJMSXhxCSEW-Sp6ztpPr_bugYPDvEUBQzupStihyYnyFgpm6tYbNO7NQSpqA5KouDv9WkaFZRdmr0&sig=Cg0ArKJSzPq3FA0eUWu0EAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 26 Aug 2019 05:12:55 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/ Frame DD22
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 01:22:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
100237
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1054
x-xss-protection
0
server
cafe
etag
18205873578609640656
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 08 Sep 2019 01:22:18 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame DD22
75 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
99019b305dcd9c03e496cf964097ae47afd65407cd9b26840e05d50560a41169
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 05:12:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1566558908912117"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28532
x-xss-protection
0
expires
Mon, 26 Aug 2019 05:12:55 GMT
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame DD22
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031404&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=116494043065&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:e914:8d8d:e7fd:f63e Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
31fbf698197fc55151f6875d09f3e1a8424dfdc8c5751b69122aac6fa84d85d4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:55 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
17405305192067880125
tpc.googlesyndication.com/simgad/ Frame DD22
77 KB
77 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/17405305192067880125
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
8151ee77422a282f8c38e0cfd5ffdd7a3319ade37c8994d4007bf451c8dd6861
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 24 Aug 2019 16:32:59 GMT
x-content-type-options
nosniff
age
131996
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
79023
x-xss-protection
0
last-modified
Thu, 02 Feb 2017 14:43:31 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 23 Aug 2020 16:32:59 GMT
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
365 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:da00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Mon, 26 Aug 2019 05:12:55 GMT
via
1.1 c26b8e74df43cd99786e716221463d0c.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
29564ad3-c7c0-11e9-9be4-0914dc53bf08
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d636a57-1c73be600b8c88a02f4c5400;Sampled=0
x-amz-apigw-id
fA2NoG0foAMF8uA=
content-length
2
x-amz-cf-id
XHosaQawdl0texac3YgHKEOXbTCjPoSi3fGqlXnzNDx67Vg-2lWtEQ==
truncated
/ Frame DD22
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
066648394e8ce564019250ae2ed1efdcd6619ade97dd7e627e5fcb2d42cd9ce3

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
ad.gif
api-54-218-116-18.b2c.com/api/ Frame 7AC4
43 B
233 B
Image
General
Full URL
https://api-54-218-116-18.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:bf44:2e7b:f554:ed7b Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
ad.gif
api-34-210-86-189.b2c.com/api/ Frame ECE4
43 B
233 B
Image
General
Full URL
https://api-34-210-86-189.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:dbba:9f1a:1862:a442 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
ad.gif
api-54-202-239-230.b2c.com/api/ Frame DD22
43 B
233 B
Image
General
Full URL
https://api-54-202-239-230.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:64cb:8ea7:59e5:800c Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:da00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Mon, 26 Aug 2019 05:12:55 GMT
via
1.1 c26b8e74df43cd99786e716221463d0c.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
29937b48-c7c0-11e9-831f-c98c8d9a4145
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d636a57-e9b758160d502a27123b7d8b;Sampled=0
x-amz-apigw-id
fA2NsH5NoAMFiRQ=
content-length
2
x-amz-cf-id
q5zr37Or4xEfmkHnBC7SdPap5tqj1HwPLA3S_T-al-6l2rXseKLx3Q==
4
api-54-218-116-18.b2c.com/api/ Frame 7AC4
Redirect Chain
  • https://api-54-218-116-18.b2c.com/api/x?e1PFsqwueEu4tciR$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RhcGFnbGlmbG96aW4tcmVkdWNlcy1yaXNrLW9mLWN2LWRlYXRoLWhvc3BpdGFsLWFkbWlzc2lvbi1pbi1oZWFydC1m...
  • https://api-54-218-116-18.b2c.com:444/api/4?e1PFsqwueEu4tciR
43 B
441 B
XHR
General
Full URL
https://api-54-218-116-18.b2c.com:444/api/4?e1PFsqwueEu4tciR
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.218.116.18 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-218-116-18.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:56 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Server
openresty
Location
https://api-54-218-116-18.b2c.com:444/api/4?e1PFsqwueEu4tciR
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-34-210-86-189.b2c.com/api/ Frame ECE4
Redirect Chain
  • https://api-34-210-86-189.b2c.com/api/x?qKckBLjFuIRU70XP$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RhcGFnbGlmbG96aW4tcmVkdWNlcy1yaXNrLW9mLWN2LWRlYXRoLWhvc3BpdGFsLWFkbWlzc2lvbi1pbi1oZWFydC1m...
  • https://api-34-210-86-189.b2c.com:444/api/4?qKckBLjFuIRU70XP
43 B
441 B
XHR
General
Full URL
https://api-34-210-86-189.b2c.com:444/api/4?qKckBLjFuIRU70XP
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.210.86.189 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-210-86-189.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:13:03 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Mon, 26 Aug 2019 05:12:56 GMT
Server
openresty
Location
https://api-34-210-86-189.b2c.com:444/api/4?qKckBLjFuIRU70XP
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-54-202-239-230.b2c.com/api/ Frame DD22
Redirect Chain
  • https://api-54-202-239-230.b2c.com/api/x?D4aBZsqOQNZEhrZu$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RhcGFnbGlmbG96aW4tcmVkdWNlcy1yaXNrLW9mLWN2LWRlYXRoLWhvc3BpdGFsLWFkbWlzc2lvbi1pbi1oZWFydC1...
  • https://api-54-202-239-230.b2c.com:444/api/4?D4aBZsqOQNZEhrZu
43 B
441 B
XHR
General
Full URL
https://api-54-202-239-230.b2c.com:444/api/4?D4aBZsqOQNZEhrZu
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.202.239.230 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-202-239-230.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:13:00 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Mon, 26 Aug 2019 05:12:56 GMT
Server
openresty
Location
https://api-54-202-239-230.b2c.com:444/api/4?D4aBZsqOQNZEhrZu
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
utsync.ashx
ml314.com/
793 B
2 KB
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=740&ct=js&pi=&fp=&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&pv=1566796375669_ott57n8bp&bl=en-us&cb=571737&return=&ht=&d=&dc=&si=1566796375669_ott57n8bp&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2672019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
897bb2ccd267bbd069714f21b6ef53b3ccd179611fadeb60ccf86d8ef1d074aa

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:54 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
486
Expires
0
ud.ashx
in.ml314.com/
20 B
698 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=2672019
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2672019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.208.174.93 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-208-174-93.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, no-cache="set-cookie"
Connection
keep-alive
Content-Length
138
Expires
Tue, 27 Aug 2019 05:12:56 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151491901843217&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151491901843217%26eid=50056
  • https://ml314.com/csync.ashx?fp=KW0mmy9999OHmZB5&person_id=5978151491901843217&eid=50056
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=KW0mmy9999OHmZB5&person_id=5978151491901843217&eid=50056
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Tue, 27 Aug 2019 01:12:55 GMT

Redirect headers

Location
https://ml314.com/csync.ashx?fp=KW0mmy9999OHmZB5&person_id=5978151491901843217&eid=50056
Date
Mon, 26 Aug 2019 05:12:55 GMT
Connection
keep-alive
Content-Length
0
BK-Server
bbed
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151491901843217
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5MTkwMTg0MzIxNxAAGg0I2NSN6wUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=b102507a09a4c8d67e28f64eefa7aa03732ba9dbe812d2580661b5446b3e34f5f4cb09cee1a4f8eb&person_id=5978151491901843217&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=b102507a09a4c8d67e28f64eefa7aa03732ba9dbe812d2580661b5446b3e34f5f4cb09cee1a4f8eb&person_id=5978151491901843217&eid=50082
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:55 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Tue, 27 Aug 2019 01:12:56 GMT

Redirect headers

date
Mon, 26 Aug 2019 05:12:56 GMT
via
1.1 google
status
307
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=b102507a09a4c8d67e28f64eefa7aa03732ba9dbe812d2580661b5446b3e34f5f4cb09cee1a4f8eb&person_id=5978151491901843217&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151491901843217%26eid=50220
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151491901843217%26eid=50220&mm_bnc&mm_bct&UUID=15615d63-6801-4900-83bb-5062ac793b5d
  • https://ml314.com/csync.ashx?fp=15615d63-6801-4900-83bb-5062ac793b5d&person_id=5978151491901843217&eid=50220
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=15615d63-6801-4900-83bb-5062ac793b5d&person_id=5978151491901843217&eid=50220
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:58 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Tue, 27 Aug 2019 01:12:58 GMT

Redirect headers

Date
Mon, 26 Aug 2019 05:12:58 GMT
Server
MT3 1514 a479bf8 master zrh-pixel-x17
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Location
https://ml314.com/csync.ashx?fp=15615d63-6801-4900-83bb-5062ac793b5d&person_id=5978151491901843217&eid=50220
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
0
Expires
Mon, 26 Aug 2019 05:12:57 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151491901843217
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151491901843217
  • https://ml314.com/csync.ashx?fp=54025932f3151c3b52e81cff0c3acf35&eid=50146&person_id=5978151491901843217
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=54025932f3151c3b52e81cff0c3acf35&eid=50146&person_id=5978151491901843217
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:58 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Tue, 27 Aug 2019 01:12:58 GMT

Redirect headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:58 GMT
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Location
https://ml314.com/csync.ashx?fp=54025932f3151c3b52e81cff0c3acf35&eid=50146&person_id=5978151491901843217
Cache-Control
no-cache
X-Server
10.45.11.102
Connection
keep-alive
Content-Length
0
Expires
0
match
ps.eyeota.net/
Redirect Chain
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2Zgj5vbRCXrzaBicYE9Y0edppXG04R-68ONCJVWmN62Y&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil
  • https://ml314.com/csync.ashx?fp=2Zgj5vbRCXrzaBicYE9Y0edppXG04R-68ONCJVWmN62Y&person_id=5978151491901843217&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
70 B
171 B
Image
General
Full URL
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
18.185.83.216 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-185-83-216.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:57 GMT
Content-Length
70
Content-Type
image/gif

Redirect headers

Date
Mon, 26 Aug 2019 05:12:57 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html; charset=utf-8
Location
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Cache-Control
private
Connection
keep-alive
Content-Length
168
Expires
Tue, 27 Aug 2019 01:12:57 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame ECE4
42 B
115 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssqXARneDLW0BJMb-dIszS5NUF0I3v2dGYwub9BHwtn5Zw7si8Tlumv4wbd2KHLfJhyCtvnivfJ3_PyUzIxSjBJqU1Kn353ChwfW18HG2A&sig=Cg0ArKJSzP-Etu3nyrfaEAE&adk=2785330797&tt=-1&bs=1585%2C1200&mtos=1047,1047,1047,1047,1047&tos=1047,0,0,0,0&p=140,428.5,230,1156.5&mcvt=1047&rs=3&ht=0&tfs=984&tls=2031&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=906&niot_cbk=930&md=2&rst=1566796374613&rpt=53&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C3844&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-4-12-20-13-48-19-0-0-0&tvt=2023&r=v&id=osdim&vs=4&uc=11&upc=0&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=728x90&itpl=3&v=20190823
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:55 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
x
api-54-218-116-18.b2c.com/api/ Frame 7AC4
0
382 B
Other
General
Full URL
https://api-54-218-116-18.b2c.com/api/x?e1PFsqwueEu4tciR$YWRibG9jayQ1MjgkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:bf44:2e7b:f554:ed7b Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:55 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-34-210-86-189.b2c.com/api/ Frame ECE4
0
382 B
Other
General
Full URL
https://api-34-210-86-189.b2c.com/api/x?qKckBLjFuIRU70XP$YWRibG9jayQ1NDAkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:dbba:9f1a:1862:a442 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:56 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-54-202-239-230.b2c.com/api/ Frame DD22
0
382 B
Other
General
Full URL
https://api-54-202-239-230.b2c.com/api/x?D4aBZsqOQNZEhrZu$YWRibG9jayQ1NTMkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:64cb:8ea7:59e5:800c Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:12:56 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame 7AC4
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjss9fiIs2qo6s-wb6Gc9Z6ARFaxqaGtoBtF4R1yr5zukd-azlCQT4KTP91f8Jw1QVKjaltE-UhkFrSPxaQYJIVEA4YDm4J6vdeB_fqTHoMg&sig=Cg0ArKJSzPnHdcjNJUTyEAE&adk=204078694&tt=-1&bs=1585%2C1200&mtos=1050,1050,1050,1050,1050&tos=1050,0,0,0,0&p=305,1052.5,555,1352.5&mcvt=1050&rs=3&ht=0&tfs=1290&tls=2340&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=1162&niot_cbk=1188&md=2&rst=1566796374866&rpt=51&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C3844&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-4-15-23-13-62-22-0-0-0&tvt=2331&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x250&itpl=3&v=20190823
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:56 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
Cookie set /
www.medtargetsystem.com/beacon/portal/ Frame 3A3C
0
0
Document
General
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F&_sid=3651babf-7e80-49f7-ae09-8001f3f97c77&_vid=87548eea-bafb-4017-acc1-e52d49e0627a&_ak=35-212-8F62AC13&_flash=false&_th=1566796372|1566796372|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Host
www.medtargetsystem.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653

Response headers

Cache-Control
no-store, no-cache, must-revalidate
Content-Encoding
gzip
Content-Type
text/html; charset=UTF-8
Date
Mon, 26 Aug 2019 05:12:56 GMT
Expires
Thu, 19 Nov 1981 08:52:00 GMT
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Pragma
no-cache
Server
Apache/2.4.7 (Ubuntu)
Set-Cookie
DMDSESSID=r9ev7vlqs6265ln79f09pflug7; path=/; HttpOnly
Vary
X-Forwarded-Proto,Accept-Encoding
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
6989
Connection
keep-alive
collect.gif
www.medtargetsystem.com/analytics/
0
313 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=87548eea-bafb-4017-acc1-e52d49e0627a&sid=3651babf-7e80-49f7-ae09-8001f3f97c77&vh=1&vt=1566796372&pt=1566796372&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&r=&t=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&p=5037.69&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:56 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
activeview
pagead2.googlesyndication.com/pcs/ Frame DD22
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsunArirlBxW53NTN8mOss33K63PqcPl18D2UpCEjmJ9LM923NgxA_P3EydsbR9Ucw2-OORMqM_DxFEz8FDN1W3tJlL334tyD1rBmnwWcuo&sig=Cg0ArKJSzFI0YbEU6-OhEAE&adk=3917873969&tt=-1&bs=1585%2C1200&mtos=1047,1047,1047,1047,1047&tos=1047,0,0,0,0&p=826,1052.5,1076,1352.5&mcvt=1047&rs=3&ht=0&tfs=1500&tls=2547&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=1385&niot_cbk=1393&md=2&rst=1566796375089&rpt=50&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C3844&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-4-17-25-13-70-24-0-0-0&tvt=2538&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x250&itpl=3&v=20190823
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:56 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
store
match.deepintent.com/usersync/114/
0
212 B
Image
General
Full URL
https://match.deepintent.com/usersync/114/store?id=UNK&ext1=3651babf-7e80-49f7-ae09-8001f3f97c77
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.192.232.20 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-192-232-20.compute-1.amazonaws.com
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Mon, 26 Aug 2019 05:12:57 GMT
server
nginx
content-type
image/gif
content-length
0
p3p
policyref='http://cdn.deepintent.com/p3p.xml', CP='NON CUR DEV TAI'
close_button2.png
cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/
1 KB
2 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/close_button2.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.52 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-52.fra6.r.cloudfront.net
Software
/
Resource Hash
f42e34b205a7c2ac4a0997e0b1eb2627e76ee8ae15ac7a15b05954827e186dd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 09 May 2019 21:30:55 GMT
via
1.1 7ce1191b390045e05b9cc74f7514b77b.cloudfront.net (CloudFront)
age
247051
etag
"74483a4bff0849849588dbf32a396fe9"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
1429
x-amz-cf-id
eR3-GycgSAV9K5Vjgfx4oOK0SgDa8VXko7YnBNQJ3ZNCNvaR6bEsuQ==
report
ads.spotible.com/creative/bmMb/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/bmMb/report?,1566796374,617003;IMPRESSION!4,1,0!5,1,0
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:58 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Cookie set rt=ifr
bcp.crwdcntrl.net/5/c=14413/rand=617739255/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%2... Frame E476
0
0
Document
General
Full URL
https://bcp.crwdcntrl.net/5/c=14413/rand=617739255/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/med=%23OpR%2397539%23Article%20Tags%20%3A%20Cardiovascular%20Disease%2CCHF%20and%20Arrhythmias%2CDiabetes%2CEndocrine%20Disorders/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653%22%7D/rt=ifr
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.76.79.46 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-76-79-46.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Host
bcp.crwdcntrl.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Accept-Encoding
gzip, deflate, br
Cookie
_cc_dc=1; _cc_id=54025932f3151c3b52e81cff0c3acf35; _cc_cc="ACZ4nGNQMDUxMDK1NDZKMzY0NUw2TjI1SrUwTE5LM0g2TkxOMzZlAILY5KwoBgQAAD5PCic%3D"; _cc_aud="ABR4nGNgYGCITc6KYoADABMFAYU%3D"
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653

Response headers

Access-Control-Allow-Origin
*
Cache-Control
no-cache
Content-Encoding
gzip
Content-Type
text/html;charset=UTF-8
Date
Mon, 26 Aug 2019 05:12:59 GMT
Expires
0
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Pragma
no-cache
Set-Cookie
_cc_id=54025932f3151c3b52e81cff0c3acf35;Path=/;Domain=crwdcntrl.net;Expires=Fri, 22-May-2020 05:05:00 GMT;SameSite=None _cc_cc="ACZ4nGNQMDUxMDK1NDZKMzY0NUw2TjI1SrUwTE5LM0g2TkxOMzZlAILY5Kzo%2F0DAzwADvNdntigyni1g%2BM%2FIyNA7HcE%2BNRnBXrdqOZy9a8NTbhj7zEl1GPPB1B5GGPvy8zuyMPbhxXNYYOwLSOxDXyxhzEunHrHB2PuXH4VrBQB%2FTEcS";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Fri, 22-May-2020 05:05:00 GMT;Max-Age=23328000;SameSite=None _cc_aud="ABR4nGNgYGCITc6KZoABJgaOK7UgBsftQ0ASAD%2B4BIY%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Fri, 22-May-2020 05:05:00 GMT;Max-Age=23328000;SameSite=None
Vary
Accept-Encoding
X-Server
10.45.16.232
Content-Length
469
Connection
keep-alive
cs.js
sb.scorecardresearch.com/c2/21948019/
0
400 B
Script
General
Full URL
https://sb.scorecardresearch.com/c2/21948019/cs.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:59 GMT
Content-Encoding
gzip
Last-Modified
Fri, 08 Apr 2011 23:11:26 GMT
ETag
"d41d8cd98f00b204e9800998ecf8427e:1349196464"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=259200
Connection
keep-alive
Content-Length
20
Expires
Thu, 29 Aug 2019 05:12:59 GMT
init-121b5si20pnxjymcwdz.js
api.b2c.com/api/
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-121b5si20pnxjymcwdz.js?isNHT=false
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:e914:8d8d:e7fd:f63e Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
9f20a0650a20348ce68e1ae958025c2734ff1cc9a883b7684b0016330a911936

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:12:59 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
collect
www.google-analytics.com/
35 B
132 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=62581692&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&ul=en-us&de=UTF-8&dt=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=lytics_refresh&ea=undefined&_u=aGDAAAAjQ~&jid=&gjid=&cid=1731879218.1566796372&tid=UA-1290429-2&_gid=963010317.1566796372&gtm=2wg8e15XFK9V6&cd20=ga_med_nomycme%2Cga_med_nht_false%2Call%2Cga_med_known&cd21=&cd22=&cd23=&cd24=&cd25=&cd26=&cd27=&cd28=&cd29=&cd30=Normal%20(68%20segments%20found)&z=514465685
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 25 Aug 2019 08:06:36 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
75983
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
up
insight.adsrvr.org/track/ Frame 7550
0
0
Document
General
Full URL
https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&upid=7fhq4wn&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.194.184.41 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-194-184-41.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
insight.adsrvr.org
:scheme
https
:path
/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&upid=7fhq4wn&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653

Response headers

status
200
date
Mon, 26 Aug 2019 05:12:59 GMT
content-type
text/html
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
collect
www.google-analytics.com/
35 B
93 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=62581692&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65762-2303653&ul=en-us&de=UTF-8&dt=Dapagliflozin%20Reduces%20Risk%20of%20CV%20Death%2C%20Hospital%20Admission%20in%20Heart%20Failure%20Trial%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=Scroll%20Depth&ea=%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial%2F&el=25%25&ev=25&_u=aGDAAAAjQ~&jid=&gjid=&cid=1731879218.1566796372&tid=UA-1290429-2&_gid=963010317.1566796372&gtm=2wg8e15XFK9V6&z=1354350785
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 25 Aug 2019 08:06:36 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
75983
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ad.gif
api-54-202-239-230.b2c.com/api/
43 B
233 B
Image
General
Full URL
https://api-54-202-239-230.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:64cb:8ea7:59e5:800c Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 26 Aug 2019 05:12:59 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
4
api-54-202-239-230.b2c.com/api/
Redirect Chain
  • https://api-54-202-239-230.b2c.com/api/x?lCmFdXwyBAnXFsg7$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RhcGFnbGlmbG96aW4tcmVkdWNlcy1yaXNrLW9mLWN2LWRlYXRoLWhvc3BpdGFsLWFkbWlzc2lvbi1pbi1oZWFydC1...
  • https://api-54-202-239-230.b2c.com:444/api/4?lCmFdXwyBAnXFsg7
43 B
441 B
XHR
General
Full URL
https://api-54-202-239-230.b2c.com:444/api/4?lCmFdXwyBAnXFsg7
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.202.239.230 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-202-239-230.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 26 Aug 2019 05:13:00 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Mon, 26 Aug 2019 05:12:59 GMT
Server
openresty
Location
https://api-54-202-239-230.b2c.com:444/api/4?lCmFdXwyBAnXFsg7
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=62581692&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-f...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_gid=1992434052.1566796387&gjid=349550700&_v=j79&z=200106176
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_v=j79&z=200106176
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_v=j79&z=200106176&slf_rd=1&random=2630009453
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_v=j79&z=200106176&slf_rd=1&random=2630009453
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.empr.com/home/news/dapagliflozin-reduces-risk-of-cv-death-hospital-admission-in-heart-failure-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65762-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:13:07 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Mon, 26 Aug 2019 05:13:07 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1731879218.1566796372&jid=1503703900&_v=j79&z=200106176&slf_rd=1&random=2630009453
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html

Verdicts & Comments Add Verdict or Comment

200 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

number| pamEnabled object| hmAds object| dataLayer object| $ function| jQuery function| cookie object| _cc14413 object| LOTCC object| Digest function| UtilityMove object| core object| __core-js_shared__ object| global object| System function| asap function| Observable function| setImmediate function| clearImmediate object| regeneratorRuntime boolean| _babelPolyfill object| googletag object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken object| google_tag_manager string| GoogleAnalyticsObject function| ga string| adTrackProxyPath string| advertTrackingApiUrl boolean| trackImpressionsViewable object| clickedAd boolean| isOverIFrame object| dfpRequests function| waitFor function| DataLayerExist function| AdSlotsRegistered function| TrackPassbackImpression function| TrackImpression function| TrackImpressionViewable function| AdClick function| checkDuplicateImpression function| callApi function| AmazonWebService function| createAdTrackingMessage function| getAJAXObject function| trackAdvert function| xdTrackAdvert function| getRenderedAd function| EventType function| getPageDetails function| getPageName function| getSection1 function| getPageType function| getDevice function| getValueFromTargets function| getPageTypeId function| getBrowser function| getUser function| getDfpTimestamp function| getCookies function| getTimeStamp function| ProcessMouseOut function| ProcessMouseOver function| processIFrameClick function| getDfpUrlFor function| getDfpUrls function| logAdvertRequested object| dataLayerService function| hmHeaderLoginState object| dfpAdSlots object| mapping object| adSlotsConfig object| allowedSlots string| hmHomeUrl string| hmAccountUrl object| hmRegisteredAds boolean| hmAdsLazyload number| hmAdsActiveRefresh boolean| hmAdsCommentsHouse boolean| hmDmdAimEnabled boolean| hmProclivityEnabled boolean| hmAdsActiveRefreshAll boolean| hmAdsBoxReposition boolean| hmAdsLytics object| adSlots number| adDebug object| hmProclivity string| cpn object| haymarketCustomEvents object| _atrk_opts function| fbq function| _fbq function| retry function| isIE10OrLater function| detectPrivateMode string| redirect object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| epas function| maropostInitTracking string| name_funnel function| _132350 string| name_funnel1 function| _13235 object| data object| ids object| epasAPI object| hm_localize object| hm_gated object| date function| isStorageSupported function| truncateItem function| storeData function| removeData function| retrieveData function| readStorage function| getExpiration object| CE2 string| __INDIVIDUAL_ONE_VERSION_ev-store_ENFORCE_SINGLETON undefined| __INDIVIDUAL_ONE_VERSION_ev-store object| TenUp object| liosetup object| jstag object| hmAuthNoncePromise function| disqus_config object| hmRegisterPrompt function| hmSetLyticsData object| adblockDetector object| pageVars object| wp function| hmOpenRegisterPrompt function| webpackJsonp object| AIM object| _ml object| google_optimize function| atrk boolean| _atrk_fired object| ns_ function| __jstag_onload undefined| initObj string| ly_cid undefined| google_measure_js_timing boolean| google_DisableInitialLoad boolean| google_noFetch number| __google_ad_urls_id object| lio string| set_domain function| domain_name function| deleteMaroClickScriptTag function| maroRecordClick function| anchor_event_add function| maroRecordTime function| maroTrackInit object| optimizely function| HMIRegistration object| ssoLogin object| ssoRegister object| pathfora number| google_unique_id object| google_reactive_ads_global_state function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| google_image_requests object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb function| ttd_dom_ready function| TTDUniversalPixelApi object| prontoTags object| ProntoCE object| ProntoDOMEvents object| _0x3ac7 function| _0x4c7e object| gtm string| string1 string| string2 string| string3 string| string4 string| string5 string| string6 string| string7 string| string8 string| string9 string| string10 number| lySegmentCounter string| result string| key function| checkForCPNSegments function| logit function| __$PP

46 Cookies

Domain/Path Name / Value
www.medtargetsystem.com/ Name: DMDSESSID
Value: r9ev7vlqs6265ln79f09pflug7
www.empr.com/ Name: _sess
Value: 3651babf-7e80-49f7-ae09-8001f3f97c77.87548eea-bafb-4017-acc1-e52d49e0627a.1566796372.1
.empr.com/ Name: __gads
Value: ID=e4e58f285fbd3edc:T=1566796373:S=ALNI_MbOul24L40fPLl-tKj2Dw71dFpaIw
www.empr.com/ Name: _ccmsi
Value: 1566796375669_ott57n8bp|1566796375669
www.empr.com/ Name: PathforaTest_f02f2b0f153194d422ec9c29d2c27075
Value: 0.6410674091789095
www.empr.com/ Name: PathforaTest_c96fbadfa4d56e10de95230f5aef1bc3
Value: 0.5212884869829044
www.empr.com/ Name: PathforaTest_beea1459cbf955aa9f2ce6e6818f14b3
Value: 0.19213381554694897
www.empr.com/ Name: PathforaTest_853e3ee5e01881b83ab49fe8c2eae359
Value: 0.01602506639707424
www.empr.com/ Name: PathforaTest_845520b7c2ad6c7b2d753bf3b76b1546
Value: 0.047558704857968204
www.empr.com/ Name: PathforaTest_354ff931e1d1ba292afc8446d8447661
Value: 0.316666352048661
www.empr.com/ Name: PathforaTest_fbcdd6902623329bbdbacbed41b3575a
Value: 0.21328431440779383
www.empr.com/ Name: PathforaTest_ba45ae1966d4458f98aad804ba43acd1
Value: 0.46155959280115355
www.empr.com/ Name: PathforaTest_16c648a7e9a8e384a49983317da2418c
Value: 0.4486242339527162
www.empr.com/ Name: dmd-vid
Value: 87548eea-bafb-4017-acc1-e52d49e0627a
www.empr.com/ Name: PathforaTest_00a2fe23f73e4b2dcdcaba9058b0c8da
Value: 0.6977806645499169
www.empr.com/ Name: dmd-3651babf-7e80-49f7-ae09-8001f3f97c77
Value: e30=
www.empr.com/ Name: PathforaPageView
Value: 1
www.empr.com/ Name: register-pages
Value: 1
.empr.com/ Name: _maro_campaign_id
Value: BAhpA+IAAQ==--989e3e5303b77c8ac6dc2f087605d140972a4746
www.empr.com/ Name: dmd-ahk
Value: ad6aa38fa8
.empr.com/ Name: seerid
Value: 74508fc76dca5391fdb5ee5585bcc1af
www.empr.com/ Name: _ccmaid
Value: 5978151491901843217
.www.empr.com/ Name: seerid
Value: 74508fc76dca5391fdb5ee5585bcc1af
www.empr.com/ Name: shadowAccount
Value: true
www.empr.com/ Name: globalAct
Value: 0
.empr.com/ Name: _maro_account_id
Value: BAhpAisF--37e0a5dc91bbd179df584d1ded7f2656371a9960
www.empr.com/ Name: dmd-sid
Value: 3651babf-7e80-49f7-ae09-8001f3f97c77
www.empr.com/ Name: PathforaTest_2c3134d8bbcf5fc7ef88d4f188d3d27a
Value: 0.7780330215273736
www.empr.com/ Name: hmSsoCheck
Value: true
.www.empr.com/ Name: seerses
Value: e
.empr.com/ Name: seerses
Value: e
www.empr.com/ Name: hmUsrc
Value: haymarket
www.empr.com/ Name: PathforaTest_799d710fa90d2ecf34854f0b95244cf7
Value: 0.032185508871662716
.empr.com/ Name: _ga
Value: GA1.2.1731879218.1566796372
www.empr.com/ Name: globalActData
Value: {%22subscriber%22:{%22firstName%22:%22Thao%22%2C%22lastName%22:%22Nguyen%22%2C%22email%22:%22nguyentt@sutterhealth.org%22%2C%22displayName%22:%22Thao%20Nguyen%22%2C%22subscriberId%22:0}%2C%22medicalData%22:{%22npiNumber%22:1619909975%2C%22hashedNpiNumber%22:%227ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%22%2C%22profession%22:{%22id%22:448%2C%22name%22:%22Physician%22}%2C%22subscriberTopics%22:[]}%2C%22publicationId%22:0%2C%22address%22:{%22city%22:%22SAN%20JOSE%22%2C%22stateCode%22:%22CA%22%2C%22postalCode%22:%2295112%22}%2C%22newsLetters%22:[]%2C%22optInMyCmeEmails%22:false%2C%22optInHmiEmails%22:false%2C%22optInThirdPartyEmails%22:false%2C%22optOutRelevantWorkEmails%22:false%2C%22optInScreenedWorkEmails%22:false%2C%22optOutScreenedWorkEmails%22:false%2C%22sendEmailConfirmation%22:false}
www.empr.com/ Name: PathforaTest_d6df9a0570056338f3892306d7656f11
Value: 0.07454906757250712
.empr.com/ Name: _gat_UA-1290429-2
Value: 1
www.empr.com/ Name: hmNpiId
Value: 1619909975
.empr.com/ Name: __asc
Value: 966a75b916ccc575a19b93e0c41
.empr.com/ Name: _maro_contact_id
Value: BAhpA6UmIw==--7a2ae91d148709d3a8aade4e018a13ff525399d3
.empr.com/ Name: __auc
Value: 966a75b916ccc575a19b93e0c41
www.empr.com/ Name: PathforaTest_c835c8fce5cb8c9ae765bcc82e287892
Value: 0.4451158302623923
.empr.com/ Name: _fbp
Value: fb.1.1566796372533.1929976899
.empr.com/ Name: _gid
Value: GA1.2.963010317.1566796372
www.empr.com/ Name: spinfo
Value: spem=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1
www.empr.com/ Name: adcpn2
Value: pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019

78 Console Messages

Source Level URL
Text
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1(Line 2)
Message:
JQMIGRATE: Migrate is installed, version 1.4.1
console-api log URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js(Line 540)
Message:
interactive
console-api log (Line 2)
Message:
DMD AIM data:{}
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1565874213(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1565874213(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1565874213(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1565874213(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log (Line 8)
Message:
logit -ga_med_nomycme
console-api log (Line 8)
Message:
logit -ga_med_nht_false
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_rheum_survey_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(3_day_visitors_neuro_ca_empr)
console-api log (Line 6)
Message:
checkForCPNSegments(blackfriday_notunknown)
console-api log (Line 6)
Message:
checkForCPNSegments(activity_5126_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_endofyearsale_noanonymous_nosdc)
console-api log (Line 6)
Message:
checkForCPNSegments(audience_for_mlk_sale)
console-api log (Line 6)
Message:
checkForCPNSegments(not_unknown_5770)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5762)
console-api log (Line 6)
Message:
checkForCPNSegments(ddw_opened_to_all)
console-api log (Line 8)
Message:
logit -all
console-api log (Line 6)
Message:
checkForCPNSegments(all)
console-api log (Line 6)
Message:
checkForCPNSegments(smt_new)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_has_visited_web)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_multi_session_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_day)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_week)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_month)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_3_months)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_known_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_repeat_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_international_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_uses_desktop)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(known)
console-api log (Line 6)
Message:
checkForCPNSegments(all_time_visitors)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4797_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_hiv_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_internal_med_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4744_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_psychiatry_all_except_4812_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cardiology_all_except_cardiology_pas)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_dermatology_all_except_4831_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_all_except_4354_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4523)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4524)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4525)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4526)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4593)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4595)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4710)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4804)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4834)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4800)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4792)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4511)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4529)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4558)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4634)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4740)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4757)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4842)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4816)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4897)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4727)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4755)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4791)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_47911)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4826)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4815)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_mpr_print_subscribers)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_ca_print_subscribers)
console-api log (Line 8)
Message:
logit -ga_med_known
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_homepage_ibs_town_wall_)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_ddw_nash)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5841_2)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_activity_5591)
console-api log (Line 5)
Message:
OK
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1565874213(Line 1)
Message:
[ABD] exiting test loop - value: false

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
accounts.haymarketmedia.com
ads.spotible.com
adservice.google.com
adservice.google.de
adtrackapi.haymarketmedia.com
api-34-210-86-189.b2c.com
api-54-202-239-230.b2c.com
api-54-218-116-18.b2c.com
api.b2c.com
api.lytics.io
bcp.crwdcntrl.net
c.lytics.io
cdn1.spotible.com
certify.alexametrics.com
connect.facebook.net
content.maropost.com
d31qbv1cthcecs.cloudfront.net
fonts.googleapis.com
fonts.gstatic.com
idsync.rlcdn.com
in.ml314.com
insight.adsrvr.org
js.adsrvr.org
link.email.empr.com
match.deepintent.com
media.empr.com
ml314.com
mpct1.maropost.com
mt.sitomobile.com
pagead2.googlesyndication.com
pixel.mathtag.com
pixel.tapad.com
ps.eyeota.net
s3.amazonaws.com
sb.scorecardresearch.com
script.crazyegg.com
securepubads.g.doubleclick.net
sp.sitomobile.com
stats.g.doubleclick.net
subapi.haymarketmedia.com
sync.crwdcntrl.net
tags.bluekai.com
tags.crwdcntrl.net
tpc.googlesyndication.com
www.empr.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medtargetsystem.com
www.renalandurologynews.com
tpc.googlesyndication.com
13.35.253.36
13.35.253.5
13.35.253.52
13.35.253.69
13.35.255.55
172.217.16.194
18.185.83.216
2.19.43.224
2.21.37.45
23.43.115.74
2600:1f14:e96:5800:bf44:2e7b:f554:ed7b
2600:1f14:e96:5800:e914:8d8d:e7fd:f63e
2600:1f14:e96:5802:64cb:8ea7:59e5:800c
2600:1f14:e96:5802:dbba:9f1a:1862:a442
2600:9000:2057:a600:1b:fadc:b780:93a1
2600:9000:2057:da00:16:bc48:4dc0:93a1
2606:4700:20::6819:5465
2606:4700::6813:9408
2a00:1450:4001:806::200a
2a00:1450:4001:814::2003
2a00:1450:4001:815::2001
2a00:1450:4001:81a::2008
2a00:1450:4001:81a::200e
2a00:1450:4001:81d::2003
2a00:1450:4001:81d::2004
2a00:1450:4001:81f::2002
2a00:1450:400c:c04::9b
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8083:face:b00c:0:25de
3.225.154.29
34.192.232.20
34.192.84.248
34.205.176.240
34.210.86.189
34.225.65.223
34.248.158.173
35.190.72.21
35.227.192.113
35.227.248.159
35.238.92.4
52.1.219.33
52.216.162.253
52.4.48.124
54.156.255.160
54.194.184.41
54.202.239.230
54.208.174.93
54.218.116.18
54.76.79.46
93.184.220.113
94.31.29.64
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
066648394e8ce564019250ae2ed1efdcd6619ade97dd7e627e5fcb2d42cd9ce3
0686f5495628a74f57776eeebe84949e2b20c52327db3cf6469c18ed2dcf48f1
0891c01a43615c445e85a7d17eab463dfc3de87d3d1e6f023a996cc1680fe586
0bf574a45ef06dba35857ee315e610bfa4feec4fa3063d2213dca5d96d1e500f
0ff97369e0e399fa511f9b1535984b315e45747aa24135dc6a02977e0d3a6477
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
1a1b6a4acf4a97fc703b565202769abae62d5a59208b11c921d878e9d5817990
1ba44d3a780525ed61938485d549740a3b649d8af5f4e8d7ba1298edf5ab4dd7
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df
1db536baa18c7d63d8b102925a272275ba864d3322402884c8ea91ddd5a3c341
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7
25ccb000d0ab50ce96b43bd31cc2abd0a9cd0afabf029dae05acd06392095ecc
2703f44ce0b0236ef2544fa6c208a1e443f0784445cbc4ddd1fdaa336295d12b
2a3c8fc442100be71fa62aecfe6c6db82d0074d9b5b982940fb96dc402afb703
2b0cf0b94f5307f8b64f855263d5de010fb74353be7a433cc5a59561cdfaaa1f
2b2f53c9542f12eef99cceef17c6dad6692fe6d3630b9a22d0f6c4bba7b55002
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443
2df541ba2dac12759f5cc36999736a318e366452d683593b713ca1a53d1e27e5
2f63e435ec7fdf67b62d37f7543608ef888fb5771fc880acc94fa749e35b06a5
31fbf698197fc55151f6875d09f3e1a8424dfdc8c5751b69122aac6fa84d85d4
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723
3622b951ea76b210435cfe0389822bfbeb3c690133e6c6fd4724c335b594420a
394db2da5efaceff8eeef044b80291c0c7c0c6d5dfe35e39d0d81e7fcd680a5f
3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20
3c0c418574419249b3fff12c4cdb9a2ad6ddc191fa025ea56d4027552487e78c
3eda2a6e0b3a7c4f5c96407a6f5f6a53786d69a998ef40bd4993cf16ccfbda0f
4029685f0104ac98118094b6adbe2ca7f8241025a320111d2647d0a867626d8a
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735
438b2323483bd093803fe7fa6121f52326259e76f6b3510d8fffc66010f550b9
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d
4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e
50abb28802f1e77b63ff2dee64a92ab7f6f2e1df12b7d66d513fa21eacca57b4
51acd6cae9a2c501f05bdfaa4d52c131e4297365de18b044d92b2cc06c2bcc9e
571f0d2fbc5d9e206f4493f5ba110a70b1c55077bc9110e8d8b5bcb115cb9140
58649dc87a82c3fe3de185bc3e5da95f8f9357899abfc780e2bd14b2988e0c05
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a
5ff91653d02d048ed74ad7a92e1aa3545b383e23333248405b6d1819f14be72b
635994bacaaafcf5296ca204df7739d714b94ad861f7156c0d3e98d5353de747
643785cbdf05e8cbc1f03dcb412c95c14bfb8eb067980c5bd7c4d7d8b805b74a
64a0cd363010895321d3015d8c7973aa9ee24623e6ba363e76d1be39b09f4bd5
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5
65c55694e657b6b8b939f93844ac6452a2b0d3ed47306b0c9190db990c21093f
65f2cba11d7a8fb4e042413fdcc6fee12e8723c6ae51bf120b49d7a429178a2e
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992
6b07a073906a8de114ba9c34d1883c735b8d0fee76c881929d7134dcbeed2ec0
6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c
6f6380177618c6862586a5621d5b0e07217ab0ccdacd0a2a1a53b86f21b9ed5d
71f52b4035a972a399f7f3c230e54b7d6fc837a839e3099a77481ba21aa971e0
78b9d63c8bb41310ea0a891534cebe975558cb83b22809a3febbca243939e910
7b9025bc821fe7e035dba945260d61e17a43699d25d06392182e81d0d565e455
7c98b3e37bc9c2a726c320f5db6e1e5a23c2c44d1a5aa35c6fb5e9ae78e64c86
7d655e8cd62ba58d86b3bc9c8e1e04a76506a4dfc852c3b3813deb0aef284548
7e357c3c78fcab868c0e3206231cb39bedf6f2edbc8db58318ff53b408acfa11
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f
8151ee77422a282f8c38e0cfd5ffdd7a3319ade37c8994d4007bf451c8dd6861
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811
8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478
890868352843ce74ea2931a4b7a4b6ef2d735badf08aa80408a66ea64492e828
897bb2ccd267bbd069714f21b6ef53b3ccd179611fadeb60ccf86d8ef1d074aa
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7
8a846df9c01f4d8d8b6e82c6e505069104280430b3b05d94a13a5b99d7c854aa
8c2303690ee0ee206f20c1f70c7b5eb29e1d592cebacb1cac0b3c7b3669e95ca
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856
90451ba3e82cd9db02f0ca76bd45d0ab5ef7e90a49da4215903cb7f08471e2e7
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2
92957755d608d90013353d5141554c10d0a2d85e0f034563c442814f91a6b1d1
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
93207da1092d103352d9b4a9234709f727472e17949513f970a7b69b96cb7177
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
9469f1c595636ba25b19f8df2801fc924192cc21f441204970d7b28c1286bbcc
9657fb8a0a588adb91904cc27ad6112de087dfc6d0f606e3a0581ab3f11f820d
99019b305dcd9c03e496cf964097ae47afd65407cd9b26840e05d50560a41169
9b2559ee95222332331b9ccf27a50e02e3edb138cce8f1a65e839facaa1d54ba
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf
9f20a0650a20348ce68e1ae958025c2734ff1cc9a883b7684b0016330a911936
a0761809c73e189d660329b14a3d67b4ed30f0666b226feb844e17eb91c852bb
a36b641fd31423f37b770f98548b729c5e0d84ec9d01f95410836cf3c0eb76e3
a9f4ae6b4905f74dfe7fb7fce1fc8ee328d1d1d085a783257fed1f970c0d9b72
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7
ad15e0951b55982ad0447c99a54cc497669f65c84ac6b12616891fec5f51223c
ad16911f49d3e72d789bfe438841576129e86d69f42bcaddf489d3523ed69951
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7
ae1eff31eff9623af795e27413312563c498759622b7c17ede94ed31b5594e89
af45e9ab0aa4ee5ede418690988f533b3e6d1223aacce6624bb66d28793b6251
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b
b2435070f04e40c2666a729a016c60355b2025c969c3b7857489b7c8b2755bc2
b3647092d3dbff1fcb9fa2a29831d7187aaa105135e08e49946b2c30f8d29a89
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad
b494e6c104ae3e24d72e47c444c6d3b290ee92274d3949806c12a71dc3d002f1
bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130
c20bb9511b5e428f8815ee2d9473a0a9c1eb96cad17caa13b3b2a292660623d0
c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d
c93e697d8038c51fe0e5002d6ff046cfe3497e03a47c302684292b3f1eeb6c46
cd1c301a8e7960a1786e2a959226b0b78b56dbea284bd114265f1662d6ca280e
cf16318f63ae35c429ae870eba98f1ea581a68200daa2e12f92c6e349f64ba0a
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78
d13db8b95f4bea4d1f6acba9dd08e9e026540e8bf28b19133c5e85d42b953b39
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531
dc613fc8436e087510e49e0277c163489f8b80c8013b8de6e3c66f813c8ce5bf
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98
e3741cb5d52b90eaf48d32a7e5413650b4cb1a47aeff1f149e5f99cd59a09ea2
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e7286d04cf4a45fbb96f9ff861edfcaf92e125ea02f4e5dc6a9282901f693b28
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5
ec4b201b52347534c07364e77ab720820b26bca36ffa7376cedfba0c25a3b796
ece5f25bbc643556099a200aa2df5c428d74048e55db71c1880afd1adcb425a9
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0
f15f778cd39043a166a29f654b1191bc6fbf8043a8cc3477c42764b14b919dec
f19fa5a10f8202dd8791086c2bc5fc7f56d9a202d46cf8a99d36e914498614f2
f21bb8fad8ff1729cf97fb2b3318e965e830bbfd2b23ebbe378205a317d240f5
f42e34b205a7c2ac4a0997e0b1eb2627e76ee8ae15ac7a15b05954827e186dd9
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f
f7ed838237ea2501ebae9e27236e22a9e57303dc65bfa03feaa5c228ee410f6b
f876042041fbf3fd3ca277c5bc8d70ae5a82769a34e186a2b7cb3b7357c52c77
f8d01ec910b326a38c827a7ad81338b72df1e3e51602f72d108ecaeff2d83160
f984c8e1978cf73d7c628f6d255ced232aab616cd77fcf720d5afb6b98fe4725
fa59ac0717445513b3e86fa270a5459f79af3e76f658270e5ad6d84cefa1b67e
fe4ee8cc9d0936f299bb1ebe179f27a4cedef239fac660cdb6e8a7827b8e85bd
ff22b4a32c2825038a9d960fd1228005fd8728bd64343b555a0ce7f17b1d2ed4